Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal English Filtered by asset PLXS
Coverage 114,310 Raw stories ingested 12,084 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 48s ago
  • FMP Forex News Fetch every 5 min 48s ago
  • CoinGecko News Fetch every 5 min 48s ago
  • FIO Stock News Fetch every 10 min 9m ago
  • Patria Stock News Fetch every 10 min 9m ago
  • Editorial rewrite Rewrite every minute 48s ago
  • Asset sync Assets every 1 hour 49m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Clear
Details Date Content Source
2026-08-05 19:11 9h ago
2026-08-05 12:51 16h ago
Plexus Q3 Beat, Strong Outlook Clouded by Free Cash Flow Concerns
PLXS Plexus
FMP Stock News
Original source text
Key Takeaways Plexus beat fiscal Q3 estimates as program ramps and industrial demand lifted sales, earnings and margins.PLXS secured 31 program wins worth $255 million annually, while its qualified funnel hit $4.5 billion.Plexus expects fiscal 2026 free cash flow usage as ramps drive working capital spending. Plexus Corp. (PLXS - Free Report) delivered a broad fiscal third-quarter beat as new program ramps and industrial demand lifted revenues, earnings and operating profitability.

The stronger outlook extends the growth runway into fiscal 2027. It also raises the near-term funding burden, making working-capital execution and free cash flow conversion central to the investment case.

Plexus Q3 Beat Was Broad-BasedFiscal third-quarter revenues increased 28.1% year over year to $1.305 billion and surpassed the Zacks Consensus Estimate of $1.228 billion by 6.3%. Adjusted earnings of $2.32 per share topped the consensus mark of $2.10, producing a 10.5% surprise.

Gross profit rose 27.2% to $131.4 million. Adjusted operating margin expanded 30 basis points to 6.3%, showing that the revenue upside translated into higher profitability despite a 41.1% increase in selling and administrative expenses.

PLXS Program Wins Expand Revenue VisibilityPlexus secured 31 manufacturing program wins during the quarter. Those awards are expected to contribute $255 million in annualized revenues once fully ramped.

The qualified manufacturing funnel reached $4.5 billion, increasing 23% year over year and 12% sequentially. The pipeline offers a sizable pool of potential awards, although program timing and conversion remain execution variables.

Plexus Guidance Extends the Growth RunwayManagement expects fiscal fourth-quarter revenues of $1.33 billion to $1.38 billion. At the midpoint, the outlook implies a 4% sequential increase and 28% year-over-year growth, while non-GAAP earnings are projected at $2.47-$2.63 per share.

Plexus now expects fiscal 2026 revenue growth above 20% and adjusted operating margin above 6%. Fiscal 2027 revenue growth is projected to exceed its 9%-12% target, accompanied by further margin expansion.

PLXS Industrial and A&D Demand Lead the MixIndustrial revenues surged 41.9% year over year and 23% sequentially to $589 million, representing 45% of total revenues. Semiconductor capital equipment demand, broader industrial activity and expansion into data-center power infrastructure and energy-storage systems supported the segment.

Aerospace and Defense revenues increased 27.3% to $233 million, while Healthcare and Life Sciences advanced 15% to $483 million. Jabil Inc. (JBL - Free Report) offers a relevant industry read-through because it cited strong AI infrastructure demand in its fiscal third-quarter 2026 results and raised its full-year AI-related revenue outlook.

Sanmina Corporation (SANM - Free Report) provides another manufacturing comparison through its exposure to industrial and energy, medical, defense and aerospace, communications networks and cloud and AI infrastructure markets.

Plexus Working Capital Clouds the Near TermFaster program ramps require more inventory, capacity and working-capital investment. Management now anticipates fiscal 2026 free cash flow usage, reversing its earlier expectation for $50-$75 million of generation.

Fiscal third-quarter operating cash flow was $25.9 million, while capital expenditures of $26.6 million produced a $0.7 million free cash outflow. Fiscal 2026 capital spending is expected at $100-$120 million, with meaningful free cash flow generation anticipated early in fiscal 2027.

PLXS Momentum Leads Its Mixed Style ProfileThe bottom line is that the earnings beat, expanding program pipeline and higher growth outlook strengthen Plexus’ operating case. Heavier investment raises cash-conversion risk and leaves less room for execution delays.

PLXS currently carries a Zacks Rank #3 (Hold), pointing to a neutral near-term earnings-revision setup rather than a top-ranked buying signal. The ranking can support retaining an existing position, but the framework generally favors Zacks Rank #1 or #2 stocks for new purchases.

The stock has a Momentum Score of A, reflecting favorable price-trend characteristics. Its Value Score of C, Growth Score of D and VGM Score of D provide weaker support across valuation, growth quality and the combined style profile, keeping cash flow execution in focus.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2026-08-05 19:11 9h ago
2026-08-05 12:51 16h ago
Should Investors Buy PLXS as Growth Accelerates but Cash Flow Weakens?
PLXS Plexus
FMP Stock News
Original source text
Key Takeaways Plexus posted 28.1% revenue growth, higher earnings and a 6.3% adjusted operating margin.Fiscal 2026 growth is seen above 20%, but free cash flow is now expected to be negative.PLXS trades above industry and historical valuation levels, limiting room for execution setbacks. Plexus Corp. (PLXS - Free Report) is producing faster revenue growth, higher earnings and wider margins as new programs ramp across its end markets. The operating momentum is clear, but the stock already reflects high expectations.

A richer valuation and a weaker near-term free cash flow outlook make the buy decision less straightforward. Investors must weigh improving execution against limited room for delays, working-capital pressure or slower margin gains.

Plexus Growth Is Accelerating SharplyFiscal third-quarter revenues increased 28.1% year over year to $1.305 billion. Adjusted earnings of $2.32 per share topped the Zacks Consensus Estimate of $2.10 and rose from $1.90 in the year-ago quarter.

Adjusted operating margin expanded 30 basis points to 6.3%. The improvement shows that higher sales are supporting profitability rather than merely adding volume, while 31 manufacturing program wins provide additional growth visibility.

PLXS Guidance Raises the Growth BarPlexus expects fiscal fourth-quarter revenues of $1.33 billion to $1.38 billion and non-GAAP earnings of $2.47-$2.63 per share. Adjusted operating margin is projected between 6.1% and 6.5%.

Management now anticipates fiscal 2026 revenue growth above 20% and adjusted operating margin above 6%. Fiscal 2027 revenue growth is expected to exceed the company’s 9%-12% goal, with further margin expansion.

Plexus Valuation Prices in Strong ExecutionPLXS trades at 30.09X forward 12-month earnings, above the sub-industry’s 22.78X and its five-year median of 18.4X. That premium leaves less room for program delays, weaker customer demand or slower-than-planned margin improvement.

Image Source: Zacks Investment Research

Jabil Inc. (JBL - Free Report) is a relevant industry reference because its recent company commentary cites demand in capital equipment, cloud and data-center infrastructure. Sanmina Corporation (SANM - Free Report) , another integrated manufacturing provider, serves industrial, medical, defense and aerospace, communications and cloud infrastructure markets.

PLXS Cash Flow and Concentration Temper the CaseThe stronger outlook requires more working capital and capacity investment. Management now expects fiscal 2026 free cash flow usage, reversing its earlier projection for $50-$75 million of generation, before a return to meaningful generation early in fiscal 2027.

Customer concentration adds execution risk. The top 10 customers generated 55% of fiscal third-quarter revenues, raising the potential impact of order delays, program losses or weaker spending by a major account.

Plexus Returns Still Support the ThesisAfter-tax return on invested capital reached 14.9% in the fiscal third quarter, compared with a weighted average cost of capital of 9%. The spread indicates that recent investments are creating economic value despite the heavier near-term funding needs.

Plexus ended the quarter with $314.1 million in cash and cash equivalents and $91.6 million in long-term debt and finance lease obligations, net of the current portion. It also repurchased $20.6 million of shares, with $21.4 million remaining under its authorization.

PLXS Signals Favor Patience Over ChasingThe bottom line is that accelerating growth and improving returns support holding PLXS, but valuation and cash flow risks argue against chasing the stock after its sharp advance.

PLXS carries a Zacks Rank #3 (Hold). The ranking can support retaining an existing position, while the preferred new-buy combinations generally pair a Zacks Rank #1 or #2 with favorable Style Scores.

The stock has a Value Score of C, Growth Score of D, Momentum Score of A and VGM Score of D. The Momentum Score points to favorable price trends, but the weaker growth and composite readings limit broad-based confirmation. Waiting for a better entry point or clearer free cash flow improvement looks more balanced than an aggressive purchase.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2026-08-04 09:30 1d ago
2026-08-04 02:15 2d ago
Plexus Corp. (NASDAQ:PLXS) Receives Consensus Recommendation of “Moderate Buy” from Analysts
PLXS Plexus
FMP Stock News
Original source text
Posted by Defense World Staff on Aug 4th, 2026

Plexus Corp. (NASDAQ:PLXS – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $273.00.

PLXS has been the topic of a number of research reports. Zacks Research raised Plexus from a “strong sell” rating to a “hold” rating in a report on Monday, July 13th. Needham & Company LLC upped their price objective on Plexus from $285.00 to $310.00 and gave the company a “buy” rating in a research note on Monday, June 1st. Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Sidoti raised Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price on the stock in a report on Friday. Finally, Weiss Ratings upgraded Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, July 6th.

Check Out Our Latest Research Report on Plexus

Plexus Stock Up 3.8% PLXS stock opened at $260.77 on Tuesday. The company has a fifty day moving average price of $273.26 and a 200 day moving average price of $234.95. Plexus has a 12 month low of $125.92 and a 12 month high of $307.06. The company has a market cap of $6.98 billion, a price-to-earnings ratio of 38.46 and a beta of 0.90. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72.

Plexus (NASDAQ:PLXS – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, topping analysts’ consensus estimates of $2.13 by $0.19. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The firm had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.23 billion. During the same quarter in the prior year, the business earned $1.64 EPS. Plexus’s quarterly revenue was up 28.2% compared to the same quarter last year. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Sell-side analysts expect that Plexus will post 5.98 earnings per share for the current year.

Insider Activity In other news, EVP Angelo Michael Ninivaggi, Jr. sold 3,270 shares of Plexus stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $264.75, for a total value of $865,732.50. Following the sale, the executive vice president owned 16,266 shares of the company’s stock, valued at $4,306,423.50. The trade was a 16.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Todd P. Kelsey sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, June 17th. The shares were sold at an average price of $294.98, for a total transaction of $442,470.00. Following the completion of the sale, the chief executive officer owned 68,888 shares of the company’s stock, valued at approximately $20,320,582.24. The trade was a 2.13% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 15,078 shares of company stock worth $4,079,705 over the last quarter. Insiders own 1.78% of the company’s stock.

Institutional Inflows and Outflows Several large investors have recently bought and sold shares of PLXS. AQR Capital Management LLC grew its stake in shares of Plexus by 103.1% during the 1st quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock worth $1,074,000 after purchasing an additional 4,255 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Plexus by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock worth $2,046,000 after buying an additional 705 shares in the last quarter. United Services Automobile Association acquired a new position in Plexus during the first quarter worth about $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Plexus by 12.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock worth $10,197,000 after buying an additional 9,078 shares during the period. Finally, Cetera Investment Advisers purchased a new position in Plexus in the second quarter valued at about $309,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.

About Plexus (Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Featured Stories Five stocks we like better than Plexus SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control Why Rare Earth Processing Could Be the Real 2027 Opportunity The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEVaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of “Hold” from Analysts

NEXT HEADLINE »Kyushu Electric Power (KYSEY) & The Competition Critical Contrast
2026-08-01 08:20 4d ago
2026-08-01 04:03 5d ago
Plexus Corp. (PLXS) Q3 2026 Earnings Call Transcript
PLXS Plexus
FMP Stock News
Original source text
Plexus Corp. (PLXS) Q3 2026 Earnings Call July 30, 2026 8:30 AM EDT

Company Participants

Shawn Harrison - Vice President of Investor Relations
Todd Kelsey - President, CEO & Director
David Abuhl - CFO & Senior VP

Conference Call Participants

David Williams - Needham & Company, LLC, Research Division
Ruben Roy - Stifel, Nicolaus & Company, Incorporated, Research Division
Melissa Dailey Fairbanks - Raymond James & Associates, Inc., Research Division
Jacob Moore - KeyBanc Capital Markets Inc., Research Division

Presentation

Operator

Good morning, everyone. Thank you for joining us for the Plexus Third Quarter Earnings Conference Call. [Operator Instructions] On the call today to answer your questions after the presentation are Todd Kelsey, President and CEO; and David Abuhl, CFO and Senior Vice President.

I will now hand the conference over to Shawn Harrison, Vice President of Investor Relations. Shawn, please go ahead.

Shawn Harrison
Vice President of Investor Relations

Good morning, and thank you for joining us today. Some of the statements made and information provided during our call today will be forward-looking statements, including, without limitation, those regarding revenue, gross margin, selling and administrative expense, operating margin, other income and expense, taxes, cash cycle, capital allocation and future business outlook. Forward-looking statements are not guarantees since there are inherent difficulties in predicting future results, and actual results could differ materially from those expressed or implied in the forward-looking statements.

For a list of factors that could cause actual results to differ materially from those discussed, please refer to the company's periodic SEC filings, particularly the risk factors in our Form 10-K filed for the fiscal year ended September 27, 2025, and the safe harbor and fair disclosure statement in our press release.

We encourage participants on the call this morning to access the live webcast and supporting materials at Plexus' website at
2026-07-30 20:17 6d ago
2026-07-30 15:05 6d ago
Plexus Q3 Earnings Call Highlights
PLXS Plexus
FMP Stock News
Original source text
This mid-cap tech stock just jumped 30%...and is still cheapPlexus NASDAQ: PLXS reported record fiscal third-quarter revenue of $1.305 billion, exceeding its guidance range and rising 12% sequentially and 28% from a year earlier, as demand strengthened across its aerospace and defense, healthcare life sciences, and industrial markets.

President and Chief Executive Officer Todd Kelsey said the company’s performance was supported by new program launches, market-share gains and supply-chain execution. Non-GAAP operating margin reached 6.3%, at the high end of guidance and 30 basis points above the prior-year period, while non-GAAP diluted earnings per share of $2.32 exceeded the company’s outlook.

Get Plexus alerts:

Kelsey also said a tornado near the company’s corporate headquarters earlier in the week caused significant damage in the local community but had no material impact on Plexus operations or headquarters.

Fiscal 2026 and 2027 Outlook For the fiscal fourth quarter, Plexus forecast revenue of $1.33 billion to $1.38 billion, which would represent 4% sequential growth and 28% year-over-year growth at the midpoint. The company guided for non-GAAP operating margin of 6.1% to 6.5% and non-GAAP EPS of $2.47 to $2.63.

The company now expects fiscal 2026 revenue growth of more than 20%, along with non-GAAP operating margin above 6%. Looking ahead, Kelsey said Plexus sees the potential for fiscal 2027 revenue growth exceeding its long-term 9% to 12% target, accompanied by operating-margin expansion and a return to meaningful free-cash-flow generation.

“Supporting our bullish outlook is continued strong growth from our aerospace and defense and industrial markets, including semiconductor capital equipment, with continued growth in Healthcare Life Sciences,” Kelsey said.

Chief Financial Officer David Abuhl said the company expects fiscal 2027 capital expenditures to remain within a range of 2% to 3% of revenue. Plexus expects fiscal 2026 capital expenditures of $100 million to $120 million and projects fiscal fourth-quarter free cash flow to be break-even or slightly negative due to working-capital investment timing. For fiscal 2027, it expects free cash flow to exceed $100 million.

Market-Sector Performance Aerospace and defense revenue rose 10% sequentially in the fiscal third quarter, exceeding the company’s expectation for a mid-single-digit increase. Plexus expects fourth-quarter revenue in the sector to be approximately flat sequentially but up more than 30% year over year. For fiscal 2026, it now expects aerospace and defense revenue growth of more than 20%, led by defense and unmanned systems.

The sector secured $135 million in new program wins during the quarter, including a secure wireless communications system for a new defense and security customer and a naval submarine electronics program. Plexus said its aerospace and defense wins totaled $400 million year to date, more than twice its combined fiscal 2024 and fiscal 2025 performance.

Healthcare life sciences revenue increased 2% sequentially, exceeding the company’s forecast for flat growth. Plexus expects flat sequential revenue in the fourth quarter, as delays in program ramps are expected to offset stronger customer demand. The company raised its fiscal 2026 expectation for the sector to high-teens year-over-year growth, while its preliminary fiscal 2027 view calls for at least mid-single-digit growth as activity normalizes after a period of product launches.

Industrial revenue increased 23% sequentially, well ahead of the company’s low-double-digit forecast. Plexus attributed the outperformance to demand in semiconductor capital equipment and other industrial subsectors, as well as operational and supply-chain execution. It expects high-single-digit to low-double-digit sequential industrial growth in the fiscal fourth quarter and more than 20% growth for fiscal 2026.

Industrial wins totaled $67 million during the quarter and included a new battery energy storage systems program for data centers. Initial production of that program is underway, according to the company. Kelsey said data-center power and thermal management are part of a broader strategy, with a data-center opportunity funnel of approximately $500 million.

Pipeline, Capacity and Cash Cycle Plexus said its qualified manufacturing opportunity funnel reached a record $4.5 billion, up 12% sequentially and 23% from a year earlier. The funnel increased by more than $800 million year over year, with aerospace and defense and industrial both reaching record levels.

To support anticipated growth, Plexus is expanding production capacity at an existing site in Penang, Malaysia. Kelsey said the project is already underway and is expected to add more than $500 million of capacity without a meaningful margin impact because it is part of an existing profitable facility. Executives said the company could support close to $6 billion in revenue with its current footprint, depending on where revenue is generated.

Third-quarter cash from operations totaled $25.9 million, while capital expenditures were $26.6 million, resulting in free cash flow usage of just under $1 million. Plexus repurchased $20.6 million of stock during the quarter and had about $21 million remaining under its current authorization.

The company ended the quarter in a net cash position, with $172 million outstanding on its revolving credit facility and more than $320 million available to borrow. Its cash cycle improved to 62 days, the best quarterly result in more than five years, while return on invested capital reached 14.9%.

About Plexus (NASDAQ:PLXS)Plexus Corp. NASDAQ: PLXS is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Plexus Right Now?Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
2026-07-30 17:52 6d ago
2026-07-30 11:30 6d ago
Plexus' Q3 Earnings Surpass Estimates, Revenues Increase Y/Y
PLXS Plexus
FMP Stock News
Original source text
Key Takeaways Plexus' fiscal Q3 EPS rose to $2.32 as revenues climbed 28.1% to $1.305 billion, topping estimates.Industrial revenues surged 41.9% to $589 million, driven by semiconductor demand and program ramps.Plexus sees Q4 revenues of $1.33-$1.38 billion and EPS of $2.47-$2.63, with 2026 growth above 20%. Plexus Corp (PLXS - Free Report) reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.32 compared with the year-ago quarter’s $1.90. The figure beat the Zacks Consensus Estimate of $2.10 per share. Management expected non-GAAP EPS to be in the band of $2.02-$2.18.

Revenues increased 28.1% to $1.305 billion and surpassed the consensus mark of $1.228 billion by 6.3%. Management expected revenues to be between $1.2 billion and $1.25 billion. Broad end-market demand, new program ramps and Industrial strength drove the performance.

In the fiscal third quarter, Plexus announced 31 manufacturing program wins, which are estimated to contribute $255 million in annualized revenues once fully ramped into production.

Shares are up 2.3% in the pre-market trading session today. In the past year, shares have gained 88.6% compared with the Electronics- Manufacturing Services industry’s growth of 49%.

Price Performance
Image Source: Zacks Investment Research

Looking at PLXS’ Segment DetailsAerospace/Defense revenues climbed 27.3% year over year and 10% sequentially to $233 million, accounting for 18% of the total. Broad demand and strong operational execution supported revenue growth. Fiscal 2026 revenues are now projected to grow more than 20%, buoyed by defense demand, while fiscal fourth-quarter revenues are expected to be flat.

 Healthcare/Life Sciences revenues increased 15% year over year and 2% sequentially to $483 million, contributing 37% of total revenues. Program ramps remained a growth driver. Fiscal 2026 revenues are projected to be in the high teens, while fiscal fourth-quarter revenues are expected to be flat.

 Industrial revenues surged 41.9% year over year and 23% sequentially to $589 million. The sector represented 45% of total revenues, up from 41% in both the prior quarter and the year-ago period. Semiconductor capital equipment and broader industrial demand and program ramps supported the growth. Management expects Industrial revenues to rise in the high-single to low-double digits sequentially in the fiscal fourth quarter while overall fiscal 2026 revenues are projected to grow more than 20%.

Our estimates for revenues from the Industrial, Healthcare/Life Sciences and Aerospace/Defense were $533.1 million, $473 million and $222 million, respectively.

Revenues from the Americas increased 37.2% year over year to $428 million. Asia-Pacific revenues increased 30.3% while EMEA revenues declined 6.8%. The company’s top 10 customers accounted for 55% of net revenues in the fiscal third quarter.

Plexus’ Operating DetailsGross profit on a GAAP basis was up 27.2% year over year to $131.4 million. Gross margin was 10.1%, unchanged from the year-ago quarter.

Selling and administrative expenses increased 41.1% from the year-ago quarter’s actuals to $70.1 million.

Adjusted operating margin expanded 30 basis points to 6.3%.

PLXS’ Cash Flow & Balance Sheet PositionAs of July 4, 2026, Plexus had cash & cash equivalents worth $314.1 million compared with $303.1 million as of April 4.

PLXS had long-term debt and finance lease obligations, net of the current portion of $91.6 million as of July 4, 2026, compared with $91 million as of April 4.

For the quarter under review, cash flows generated from operations were $25.9 million. Plexus reported a free cash outflow of $0.7 million after incurring capital expenditures of $26.6 million.

The company repurchased $20.6 million worth of shares at an average price of $258.75 per share under its repurchase program in the fiscal third quarter. Out of the $100 million authorization, $21.4 million remains available.

PLXS' Q4 Guidance Signals More GrowthFor the fiscal fourth quarter, revenues are projected between $1.33 billion and $1.38 billion. At the midpoint, the revenue outlook implies a 4% sequential rise and 28% year-over-year growth.

Non-GAAP EPS is expected to be in the band of $2.47-$2.63, while adjusted operating margin is forecasted in the 6.1-6.5% range.

Management now expects fiscal 2026 revenue growth above 20% and adjusted operating margin  greater than 6%. Fiscal 2027 revenue growth is expected to exceed the 9-12% goal, alongside further margin expansion.

The stronger outlook also requires more working capital investments. Management now anticipates fiscal 2026 free cash flow usage.  Earlier, Plexus projected free cash flow to be $50-$75 million for fiscal 2026. The company expects to return to meaningful free cash flow generation early in fiscal 2027.

Zacks Rank of PLXSPlexus currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Recent Performance of Other Companies in Tech SpaceJabil Inc (JBL - Free Report) reported third-quarter fiscal 2026 results wherein core earnings of $3.16 per share increased 23.9% year over year and topped the Zacks Consensus Estimate of $3.12 by 1.28%. Net revenues rose 11.8% to $8.75 billion and exceeded the consensus mark of $8.63 billion by 1.39%. Jabil’s Intelligent Infrastructure remained the key growth engine, with segment revenues climbing 21% year over year. Over the past year, shares of JBL have gained 26.8%.

Sanmina Corporation (SANM - Free Report) reported third-quarter fiscal 2026 earnings, wherein non-GAAP EPS stood at $3.31, beating the Zacks Consensus Estimate of $2.78. Revenues of $3.46 billion exceeded the Zacks Consensus Estimate of $3.43 billion. Management added that strong execution across both core Sanmina operations and the ZT Systems business supported expansion. Over the past year, shares of SANM have gained 41.4%.

Celestica’s (CLS - Free Report) second-quarter 2026 adjusted earnings were $2.54 per share, which surged 82.7% year over year, and topped the Zacks Consensus Estimate by 10.9%. Revenues increased 62.4% to $4.7 billion and topped the consensus mark by 8.1%. Momentum in Connectivity & Cloud Solutions remained the key catalyst for Celestica. Over the past year, shares of CLS have gained 61.6%.
2026-07-30 01:03 7d ago
2026-07-29 19:26 7d ago
Plexus (PLXS) Surpasses Q3 Earnings and Revenue Estimates
PLXS Plexus
FMP Stock News
Original source text
Plexus (PLXS - Free Report) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.1 per share. This compares to earnings of $1.9 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +10.48%. A quarter ago, it was expected that this electronic manufacturing services company would post earnings of $1.87 per share when it actually produced earnings of $2.05, delivering a surprise of +9.63%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Plexus, which belongs to the Zacks Electronics - Manufacturing Services industry, posted revenues of $1.3 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 6.27%. This compares to year-ago revenues of $1.02 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Plexus shares have added about 70.1% since the beginning of the year versus the S&P 500's gain of 8.5%.

What's Next for Plexus?While Plexus has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Plexus was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.25 on $1.26 billion in revenues for the coming quarter and $8.18 on $4.72 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Electronics - Manufacturing Services is currently in the top 3% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the broader Zacks Computer and Technology sector, Silicon Laboratories (SLAB - Free Report) , is yet to report results for the quarter ended June 2026.

This chipmaker is expected to post quarterly earnings of $0.67 per share in its upcoming report, which represents a year-over-year change of +509.1%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Silicon Laboratories' revenues are expected to be $229.55 million, up 19% from the year-ago quarter.
2026-07-30 01:03 7d ago
2026-07-29 20:01 7d ago
Here's What Key Metrics Tell Us About Plexus (PLXS) Q3 Earnings
PLXS Plexus
FMP Stock News
Original source text
Plexus (PLXS - Free Report) reported $1.3 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 28.1%. EPS of $2.32 for the same period compares to $1.90 a year ago.

The reported revenue represents a surprise of +6.27% over the Zacks Consensus Estimate of $1.23 billion. With the consensus EPS estimate being $2.10, the EPS surprise was +10.48%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Plexus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenue- Market Sector- Healthcare/Life Sciences: $483 million compared to the $473.02 million average estimate based on two analysts. The reported number represents a change of +15% year over year.Revenue- Market Sector- Aerospace/Defense: $233 million versus $221.23 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +27.3% change.Revenue- Market Sector- Industrial: $589 million versus the two-analyst average estimate of $534.82 million. The reported number represents a year-over-year change of +41.9%.View all Key Company Metrics for Plexus here>>>

Shares of Plexus have returned -16.8% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
2026-07-29 22:39 7d ago
2026-07-29 16:15 7d ago
Plexus Announces Fiscal Third Quarter Financial Results
PLXS Plexus
FMP Stock News
Original source text
NEENAH, WI, July 29, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal third quarter ended July 4, 2026, and guidance for our fiscal fourth quarter ending October 3, 2026.

Reports record fiscal third quarter 2026 revenue of $1.305 billion, GAAP operating margin of 4.7% and GAAP diluted EPS of $1.58.Reports fiscal third quarter 2026 non-GAAP operating margin of 6.3% and non-GAAP diluted EPS of $2.32, excluding $0.74 of stock-based compensation expense.Initiates fiscal fourth quarter 2026 revenue guidance of $1.330 billion to $1.380 billion with GAAP diluted EPS of $2.18 to $2.34, including $0.29 of stock-based compensation expense. Fiscal fourth quarter non-GAAP EPS guidance of $2.47 to $2.63 excludes stock-based compensation expense.
   Three Months Ended July 4, 2026 July 4, 2026 Oct 3, 2026 Q3F26 Results Q3F26 Guidance Q4F26 GuidanceSummary GAAP Items     Revenue (in billions)$1.305  $1.200 to $1.250 $1.330 to $1.380Operating margin 4.7% 4.1% to 4.5% 5.5% to 5.9%Diluted EPS$1.58  $1.25 to $1.41 $2.18 to $2.34      Summary Non-GAAP Items (1)     Adjusted operating margin (2) 6.3% 5.9% to 6.3% 6.1% to 6.5%Adjusted EPS (3)$2.32  $2.02 to $2.18 $2.47 to $2.63Return on invested capital (ROIC) 14.9%    Economic return 5.9%     (1)Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.(2)Excludes stock-based compensation expense of approximately 160 bps for Q3F26 results, 180 bps for Q3F26 guidance and 60 bps for Q4F26 guidance.(3)Excludes stock-based compensation expense, net of tax, of $0.74 for Q3F26 results, $0.77 for Q3F26 guidance and $0.29 for Q4F26 guidance.   Fiscal Third Quarter 2026 Information

Won 31 manufacturing programs during the quarter representing $255 million in annualized revenue when fully ramped into production.Purchased $20.6 million of our shares at an average price of $258.75 per share under our 2026 Share Repurchase Program, leaving $21.4 million available under our existing $100.0 million authorization. Todd Kelsey, President and Chief Executive Officer, commented, “Plexus generated record quarterly revenue in the fiscal third quarter by capturing strengthening end market demand and successfully launching numerous new programs. Fiscal third quarter revenue of $1.305 billion exceeded guidance, increasing 12% sequentially and 28% year over year. In addition, non-GAAP operating margin of 6.3% met the high end of guidance, non-GAAP EPS of $2.32 exceeded guidance and we again delivered healthy working capital efficiency.”  

Mr. Kelsey added, “Our go-to-market team continued to drive strong performance with quarterly manufacturing wins of $255 million in annualized revenue. This result included significant wins for our Aerospace/Defense market sector as well as a new partnership in our Industrial market sector manufacturing a battery energy storage system for data centers. Furthermore, we expanded our funnel of qualified manufacturing opportunities to $4.5 billion, a record level, supporting the potential to sustain robust long-term revenue growth.”

David Abuhl, Senior Vice President and Chief Financial Officer, commented, “Driven by continued progress on our working capital initiatives, our cash cycle of 62 days exceeded expectations. This outstanding result is the best quarterly cash cycle performance in over five years. In support of accelerating revenue growth, we had a slight usage of free cash flow in the quarter, which was better than our expectations. While we expect to maintain cash cycle days in the low-to-mid 60s for the fiscal fourth quarter, further working capital investments are required to support our substantial revenue growth projections. As such, we now expect a usage of free cash flow for fiscal 2026 with a return to meaningful free cash flow generation in early fiscal 2027.”

Mr. Abuhl continued, “Our favorable cash cycle days, prudent capital expenditures and strong operating performance produced a return on invested capital of 14.9% in the quarter, up 110 basis points versus the prior quarter and 590 basis points above our cost of capital. This result represented the highest return in nearly five years.”

Mr. Kelsey continued, “For our fiscal fourth quarter, we forecast continued revenue growth led by strength in our Healthcare/Life Sciences and Industrial market sectors, including our semiconductor capital equipment subsector. We are guiding revenue of $1.330 to $1.380 billion, up 4% sequentially and 28% year over year at the midpoint, non-GAAP operating margin of 6.1% to 6.5% and non-GAAP EPS of $2.47 to $2.63. For fiscal 2026, we now anticipate generating in excess of 20% revenue growth due to Plexus’ success in launching numerous new programs and our market share gains combined with improved end market demand. Additionally, we expect to deliver this considerable revenue growth with greater than 6% non-GAAP operating margin and healthy working capital efficiency.”

Mr. Kelsey concluded, “Our differentiated value proposition, focused on providing unmatched quality and delivery, is resulting in robust performance for fiscal 2026 and positions Plexus for sustained, long-term momentum. We currently see the potential to generate fiscal 2027 revenue growth in excess of our 9% to 12% goal led by our Aerospace/Defense and Industrial market sectors, including our semiconductor capital equipment subsector. In addition, we anticipate delivering operating margin expansion, while continuing to make important investments in talent and technology in support of future growth.”

  Quarterly ComparisonThree Months Ended(in thousands, except EPS)July 4, 2026 Apr 4, 2026 Jun 28, 2025Revenue$1,304,778  $1,163,757  $1,018,308 Gross profit 131,379   119,176   103,288 Operating income 61,260   61,837   53,608 Net income 42,993   49,809   45,116 Diluted EPS$1.58  $1.82  $1.64       Gross margin 10.1%  10.2%  10.1%Operating margin 4.7%  5.3%  5.3%      ROIC (1) 14.9%  13.8%  14.1%Economic return (1) 5.9%  4.8%  5.2%      (1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.  Business Segment and Market Sector Revenue

Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised 55% of revenue during the third quarter of fiscal 2026. This is up 1 percentage point from the second quarter of fiscal 2026 and up 7 percentage points from the third quarter of fiscal 2025.

Business Segments ($ in millions)Three Months Ended  July 4, 2026 Apr 4, 2026 Jun 28, 2025Americas$428  $397  $312 Asia-Pacific 774   652   594 Europe, Middle East and Africa 109   116   117 Elimination of inter-segment sales (6)  (1)  (5)Total Revenue$1,305  $1,164  $1,018         Market Sectors ($ in millions)Three Months Ended July 4, 2026 Apr 4, 2026 Jun 28, 2025Aerospace/Defense$233 18% $212 18% $183 18%Healthcare/Life Sciences 483 37%  473 41%  420 41%Industrial 589 45%  479 41%  415 41%Total Revenue$1,305   $1,164   $1,018                  Non-GAAP Supplemental Information

Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow, because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.

ROIC and Economic Return

ROIC for the third quarter of fiscal 2026 was 14.9%. Plexus defines ROIC as tax-effected annualized adjusted operating income divided by average invested capital over a four-quarter period for the third fiscal quarter. Invested capital is defined as equity plus debt and operating lease obligations, less cash and cash equivalents. Plexus' weighted average cost of capital for fiscal 2026 is 9.0%. ROIC for the third quarter of fiscal 2026 less Plexus’ weighted average cost of capital resulted in an economic return of 5.9%.

Free Cash Flow

Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended July 4, 2026, cash flows provided by operations was $25.9 million and capital expenditures were $26.6 million, which resulted in a usage of free cash flow of $0.7 million.

Cash Cycle DaysThree Months Ended July 4, 2026 Apr 4, 2026 Jun 28, 2025Days in Accounts Receivable56  55  59 Days in Contract Assets13  12  13 Days in Inventory116  120  128 Days in Accounts Payable(76) (74) (72)Days in Advanced Payments(47) (49) (59)Annualized Cash Cycle (1)62  64  69  (1)Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.   Conference Call and Webcast Information

What:   Plexus Fiscal 2026 Q3 Earnings Conference Call and WebcastWhen:   Thursday, July 30, 2026 at 8:30 a.m. Eastern TimeWhere:   Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below:Webcast link:
https://events.q4inc.com/attendee/435522461

Replay:   The webcast will be archived on the Plexus website and will be available as on-demand for 12 months   Investor and Media Contact
Shawn Harrison
+1.920.969.6325
[email protected]

About Plexus
At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For more information about Plexus, visit our website at www.plexus.com.

Safe Harbor and Fair Disclosure Statement
The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of shortages, delays and price fluctuations in obtaining components as a result of economic cycles, capacity constraints, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate engagement terms, and the lack of a track record of order volume and timing; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customers and deliver product on a timely basis; the risks of concentration of work for certain customers; the effects of start-up costs of new programs and facilities or the costs associated with winding down programs or the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of the economy regionally or globally; the effect of changes in the pricing and margins of our services; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and regulatory matters in the United States and in the other countries in which we do business; the potential effect of other events outside our control, such as the conflict between Russia and Ukraine, conflict in the Middle East (including in Iran), escalating tensions between China and Taiwan or China and the United States, tensions in or amongst countries in which we operate or transact business; changes in energy prices, terrorism, global health epidemics and weather events; the impact of increased competition; an inability to successfully manage human capital, including succession planning for and transition of senior executives; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2025 Form 10-K.

 PLEXUS CORP. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data)(unaudited)       Three Months Ended Nine Months Ended Jul 4, Jun 28, Jul 4, Jun 28, 2026 2025 2026 2025Net sales$1,304,778  $1,018,308  $3,538,387  $2,974,600 Cost of sales 1,173,399   915,020   3,181,694   2,672,869 Gross profit 131,379   103,288   356,693   301,731 Operating expenses:       Selling and administrative expenses 70,119   49,680   179,132   147,789 Restructuring and other charges, net —   —   —   4,683 Operating income 61,260   53,608   177,561   149,259 Other income (expense):       Interest expense (4,089)  (2,501)  (10,399)  (9,192)Interest income 1,463   934   3,259   3,039 Miscellaneous, net (2,185)  (2,205)  (5,063)  (4,753)Income before income taxes 56,449   49,836   165,358   138,353 Income tax expense 13,456   4,720   31,374   16,897 Net income$42,993  $45,116  $133,984  $121,456 Earnings per share:       Basic$1.61  $1.67  $5.01  $4.48 Diluted$1.58  $1.64  $4.90  $4.39 Weighted average shares outstanding:       Basic 26,712   27,059   26,745   27,084 Diluted 27,294   27,532   27,347   27,670                  PLEXUS CORP. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(in thousands)(unaudited)  Jul 4, Sep 27, 2026 2025ASSETS   Current assets:   Cash and cash equivalents$314,053  $306,464 Restricted cash 514   294 Accounts receivable 795,159   656,573 Contract assets 193,942   150,654 Inventories 1,488,391   1,229,839 Prepaid expenses and other 103,285   54,969 Total current assets 2,895,344   2,398,793 Property, plant and equipment, net 546,159   546,052 Operating lease right-of-use assets 66,560   72,863 Deferred income taxes 95,173   91,349 Other assets 30,361   28,053 Total non-current assets 738,253   738,317 Total assets$3,633,597  $3,137,110     LIABILITIES AND SHAREHOLDERS’ EQUITY   Current liabilities:   Current portion of long-term debt and finance lease obligations$183,814  $45,793 Accounts payable 978,899   726,597 Advanced payments from customers 602,933   575,850 Accrued salaries and wages 111,557   109,076 Other accrued liabilities 68,563   61,367 Total current liabilities 1,945,766   1,518,683 Long-term debt and finance lease obligations, net of current portion 91,644   91,987 Long-term operating lease liabilities 23,888   29,422 Deferred income taxes 7,322   6,000 Other liabilities 36,225   36,430 Total non-current liabilities 159,079   163,839 Total liabilities 2,104,845   1,682,522 Shareholders’ equity:   Common stock 549   547 Additional paid-in-capital 710,372   695,653 Common stock held in treasury (1,319,506)  (1,255,451)Retained earnings 2,130,012   1,996,028 Accumulated other comprehensive income 7,325   17,811 Total shareholders’ equity 1,528,752   1,454,588 Total liabilities and shareholders’ equity$3,633,597  $3,137,110      PLEXUS CORP. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(in thousands)(unaudited)     Nine Months Ended Jul 4, Jun 28, 2026 2025Cash flows from operating activities   Net income$133,984  $121,456 Adjustments to reconcile net income to net cash flows from operating activities:   Depreciation and amortization 57,357   58,509 Share-based compensation expense and related charges 36,820   22,466 Other, net (211)  (8,381)Changes in operating assets and liabilities, excluding impacts of currency:   Accounts receivable (140,201)  (37,265)Contract assets (43,250)  (24,090)Inventories (259,911)  37,543 Other current and non-current assets (47,874)  (1,262)Accrued income taxes payable (3,930)  (13,361)Accounts payable 271,371   88,902 Advanced payments from customers 27,444   (118,276)Other current and non-current liabilities 7,389   (9,028)Cash flows provided by operating activities 38,988   117,213 Cash flows from investing activities   Payments for property, plant and equipment (74,312)  (60,441)Other, net (258)  (412)Cash flows used in investing activities (74,570)  (60,853)Cash flows from financing activities   Borrowings under debt agreements 605,500   293,500 Payments on debt and finance lease obligations (476,674)  (402,875)Debt issuance costs (1,108)  — Repurchases of common stock (64,055)  (43,807)Payments related to tax withholding for share-based compensation (21,473)  (15,100)Cash flows provided by (used in) financing activities 42,190   (168,282)Effect of exchange rate changes on cash and cash equivalents 1,201   2,077 Net increase (decrease) in cash and cash equivalents and restricted cash 7,809   (109,845)Cash and cash equivalents and restricted cash:   Beginning of period 306,758   347,462 End of period$314,567  $237,617      PLEXUS CORP. AND SUBSIDIARIESNON-GAAP SUPPLEMENTAL INFORMATION Table 1(in thousands, except per share data)(unaudited)           Three Months Ended Nine Months Ended Jul 4, Apr 4, Jun 28, Jul 4, Jun 28, 2026 2026 2025 2026 2025Operating income, as reported$61,260  $61,837  $53,608  $177,561  $149,259 Operating margin, as reported 4.7%  5.3%  5.3%  5.0%  5.0%          Non-GAAP adjustments:         Restructuring costs (1) —   —   —   —   4,683 Stock-based compensation (2) 21,137   7,922   7,691   36,824   21,813 Non-GAAP operating income$82,397  $69,759  $61,299  $214,385  $175,755 Non-GAAP operating margin 6.3%  6.0%  6.0%  6.1%  5.9%          Net income, as reported$42,993  $49,809  $45,116  $133,984  $121,456           Non-GAAP adjustments:         Restructuring costs, net of tax (1) —   —   —   —   4,191 Stock-based compensation, net of tax (2) 20,337   6,055   7,307   33,769   20,722 Adjusted net income$63,330  $55,864  $52,423  $167,753  $146,369           Diluted earnings per share, as reported$1.58  $1.82  $1.64  $4.90  $4.39           Non-GAAP per share adjustments:         Restructuring costs, net of tax (1) —   —   —   —   0.15 Stock-based compensation, net of tax (2) 0.74   0.23   0.26   1.23   0.75 Adjusted diluted earnings per share$2.32  $2.05  $1.90  $6.13  $5.29  (1)During the nine months ended June 28, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company’s workforce in the EMEA and AMER regions. (2)During the three and nine months ended July 4, 2026, $12.9 million, or $12.5 million net of taxes ($0.46 per diluted share), of accelerated stock-based compensation expense was recorded in selling and administrative expenses in the accompanying Condensed Consolidated Statements of Operations as a result of previously announced executive retirement agreements.   PLEXUS CORP. AND SUBSIDIARIES
NON-GAAP SUPPLEMENTAL INFORMATION Table 2
(in thousands)
(unaudited)
       ROIC and Economic Return CalculationsNine Months Ended Six Months Ended Nine Months Ended Jul 4, Apr 4, Jun 28, 2026 2026
 2025Operating income, as reported $177,561   $116,301   $149,259 Restructuring and other charges, net  —    —    4,683 Accelerated stock-based compensation (1)+ 12,940  + —  + — Adjusted operating income $190,501   $116,301   $153,942  ÷ 3  x 2  ÷ 3   $63,500        $51,314  x 4       x 4 Adjusted annualized operating income $254,000   $232,602   $205,256 Adjusted effective tax ratex 16% x 17% x 11%Tax impact  40,640    39,542    22,578 Adjusted operating income (tax-effected) $213,360   $193,060   $182,678               Average invested capital÷$1,431,266  ÷$1,401,134  ÷$1,298,575 ROIC  14.9%   13.8%   14.1%Weighted average cost of capital- 9.0% - 9.0% - 8.9%Economic return  5.9%   4.8%   5.2% Average Invested Capital CalculationsJul 4, Apr 4, Jan 3, Sep 27, 2026 2026 2026 2025Equity$1,528,752  $1,489,800  $1,481,063  $1,454,588 Plus:             Debt and finance lease obligations - current 183,814   143,112   66,837   45,793 Operating lease obligations - current (2) 7,616   7,758   7,943   8,253 Debt and finance lease obligations - long-term 91,644   91,034   91,139   91,987 Operating lease obligations - long-term 23,888   25,769   27,327   29,422 Less: Cash and cash equivalents (314,053)  (303,133)  (248,825)  (306,464) $1,521,661  $1,454,340  $1,425,484  $1,323,579         Average Invested Capital CalculationsJun 28, Mar 29, Dec 28, Sep 28, 2025 2025 2024 2024Equity$1,419,085  $1,351,675  $1,319,069  $1,324,825 Plus:               Debt and finance lease obligations - current 50,678   121,014   121,977   157,325 Operating lease obligations - current (2) 8,470   9,968   14,875   14,697 Debt and finance lease obligations - long-term 92,215   88,761   88,728   89,993 Operating lease obligations - long-term 31,192   32,720   35,124   32,275 Less: Cash and cash equivalents (237,567)  (310,531)  (317,161)  (345,109) $1,364,073  $1,293,607  $1,262,612  $1,274,006  (1)During the three and nine months ended July 4, 2026, $12.9 million of accelerated stock-based compensation expense was recorded in selling and administrative expenses in the accompanying Condensed Consolidated Statements of Operations as a result of previously announced executive retirement agreements.(2)Included in other accrued liabilities on the Condensed Consolidated Balance Sheets.  
2026-07-28 13:01 8d ago
2026-07-28 04:09 9d ago
Castleark Management LLC Purchases New Position in Plexus Corp. $PLXS
PLXS Plexus
FMP Stock News
Original source text
Posted by Defense World Staff on Jul 28th, 2026

Castleark Management LLC purchased a new position in Plexus Corp. (NASDAQ:PLXS – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 24,680 shares of the technology company’s stock, valued at approximately $4,999,000. Castleark Management LLC owned 0.09% of Plexus at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of PLXS. AQR Capital Management LLC raised its stake in shares of Plexus by 103.1% during the 1st quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock worth $1,074,000 after buying an additional 4,255 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Plexus by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock valued at $2,046,000 after acquiring an additional 705 shares during the period. United Services Automobile Association purchased a new stake in Plexus in the 1st quarter worth $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Plexus by 12.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock worth $10,197,000 after acquiring an additional 9,078 shares during the period. Finally, Cetera Investment Advisers acquired a new position in Plexus during the second quarter worth $309,000. 94.45% of the stock is owned by institutional investors and hedge funds.

Insider Activity In related news, CEO Todd P. Kelsey sold 3,000 shares of Plexus stock in a transaction that occurred on Tuesday, May 5th. The shares were sold at an average price of $268.45, for a total value of $805,350.00. Following the completion of the transaction, the chief executive officer owned 74,888 shares in the company, valued at approximately $20,103,683.60. The trade was a 3.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Victor (Pang Hau) Tan sold 3,000 shares of the business’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $271.23, for a total transaction of $813,690.00. Following the completion of the transaction, the insider owned 10,457 shares of the company’s stock, valued at approximately $2,836,252.11. This trade represents a 22.29% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 20,481 shares of company stock valued at $5,519,183. 1.78% of the stock is currently owned by company insiders.

Plexus Trading Down 0.4% Shares of Plexus stock opened at $253.38 on Tuesday. The stock has a 50 day moving average of $274.29 and a 200 day moving average of $231.82. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.54. The firm has a market capitalization of $6.78 billion, a price-to-earnings ratio of 37.04 and a beta of 0.88. Plexus Corp. has a fifty-two week low of $123.36 and a fifty-two week high of $307.06.

Plexus (NASDAQ:PLXS – Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The technology company reported $2.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.18. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The firm had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.13 billion. During the same period in the previous year, the firm earned $1.66 EPS. Plexus’s revenue was up 18.7% on a year-over-year basis. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. As a group, research analysts predict that Plexus Corp. will post 5.98 earnings per share for the current year.

Analyst Ratings Changes PLXS has been the topic of several research analyst reports. Raymond James Financial reiterated an “outperform” rating and issued a $275.00 target price on shares of Plexus in a research report on Thursday, April 30th. Weiss Ratings upgraded Plexus from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, July 6th. Stifel Nicolaus boosted their price objective on Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a research note on Monday, June 22nd. Zacks Research raised Plexus from a “strong sell” rating to a “hold” rating in a report on Monday, July 13th. Finally, Needham & Company LLC raised their target price on Plexus from $285.00 to $310.00 and gave the company a “buy” rating in a research report on Monday, June 1st. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $246.67.

Get Our Latest Stock Analysis on Plexus

Plexus Company Profile (Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Read More Five stocks we like better than Plexus AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There? Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECastleark Management LLC Cuts Position in Lumentum Holdings Inc. $LITE

NEXT HEADLINE »Castleark Management LLC Buys 2,480 Shares of First Solar, Inc. $FSLR
2026-07-15 22:20 21d ago
2026-07-15 16:15 21d ago
Plexus Sets Fiscal Third Quarter 2026 Earnings Release Date
PLXS Plexus
FMP Stock News
Original source text
NEENAH, WI, July 15, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) announced today it will release its fiscal third quarter 2026 results after market close on Wednesday, July 29, 2026. Plexus’ management will host a conference call to discuss its fiscal third quarter 2026 results on Thursday, July 30, 2026 at 8:30 a.m. Eastern Time. An audio webcast of the call and accompanying slides will be available in the investor relations section of the company website, plexus.com.

What:Plexus Fiscal Q3 2026 Earnings Conference Call and WebcastWhen:Thursday, July 30, 2026 at 8:30 a.m. Eastern TimeWhere: Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below:Webcast link: https://events.q4inc.com/attendee/435522461

Replay:The webcast will be archived on the Plexus website and will be available as on-demand for 12 months Investor and Media Contact

Shawn Harrison
+1.920.969.6325
[email protected]

About Plexus Corp.

At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For more information about Plexus, visit our website at www.plexus.com.
2026-06-26 01:28 1mo ago
2026-06-25 18:50 1mo ago
Is Plexus Corp (PLXS) Overvalued After 3.6% Rally? GF Value Says Overvalued
PLXS Plexus
FMP Stock News
Original source text
On June 25, 2026, Plexus Corp PLXS shares rose 3.6% today, trading at $296.79. Over the past year, the stock has experienced significant volatility, with a 52-week high of $307.06 and a low of $115.35.

GF Value™ verdict: Current price is $296.79 vs GF Value™ of $148.43, indicating a 100.0% overvaluation.GF Score™ of 83/100 signifies a strong ranking in terms of financial health and performance potential.Notable insider activity shows that insiders sold $6.0M in shares over the last three months, with no buying activity reported. Is PLXS Overvalued or Undervalued? Plexus Corp PLXS is currently trading significantly above its GF Value™, which is estimated at $148.43. This indicates that the stock is overvalued by approximately 100.0%, suggesting a lack of margin of safety for potential investors. The GF Valuation label classifies the stock as "Significantly Overvalued," which raises concerns about the sustainability of its current price level. With such a high valuation relative to intrinsic value, there is an increased risk of a price correction should the market adjust its perception of the company's worth.

GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates. Given the substantial disparity between the current trading price and the GF Value™, investors could face potential losses if the stock price converges toward its intrinsic value.

How Does PLXS's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 43.4x 21.8x Forward P/E 31.5x N/A The current P/E (TTM) of 43.4x is almost 99% above its 5-year median P/E of 21.8x, indicating that Plexus is trading at a premium compared to its historical valuation. This analysis aligns with the GF Value™ verdict, reinforcing the perspective that PLXS is overvalued. The elevated P/E ratio suggests that investors may be paying considerably more for each unit of earnings than they have historically, which may not be sustainable in the long run.

What Does PLXS's GF Score™ Tell Us? Metric Rating GF Score™ 83 Financial Strength 8/10 Profitability 9/10 Growth 10/10 Valuation 1/10 Momentum 6/10 The GF Score™ of 83/100 reflects a strong overall profile for Plexus Corp, driven primarily by high scores in the Growth (10/10) and Profitability (9/10) categories. However, the Valuation score of 1/10 highlights a significant weakness in the stock's current pricing relative to its intrinsic value. This dichotomy suggests that while the company may be performing well financially and exhibiting solid growth potential, the market's current valuation may not accurately reflect these strengths.

What Are Insiders Doing with PLXS Stock? Recent insider activity at Plexus Corp indicates a trend of selling, with insiders offloading $6.0 million worth of shares in the past three months. The absence of insider buying during this timeframe may signal a lack of confidence among executives regarding the stock's current valuation. Such selling activity can often be interpreted as a cautious approach by insiders, especially in a context where the stock is trading significantly above its established GF Value™.

This pattern of insider selling could suggest that even those within the company believe that the current price may not be justified, which could further concern potential investors about the stock's sustainability at elevated price levels.

What This Means for Investors Based on the analysis of Plexus Corp's valuation metrics and GF Value™, it is evident that the stock is currently overvalued. The significant disparity between the market price and intrinsic value raises red flags for potential investors. As such, caution is warranted when considering an investment in PLXS at this time.

For the complete analysis, visit the Plexus Corp PLXS stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is PLXS's GF Score™?

The GF Score™ for Plexus Corp is 83/100, indicating a strong performance potential and financial health compared to other stocks.

Is PLXS overvalued or undervalued?

Plexus Corp is considered overvalued, as its current price of $296.79 is significantly above the GF Value™ of $148.43.

What is PLXS's P/E ratio?

PLXS has a trailing P/E ratio of 43.4, which is well above its 5-year median of 21.8, highlighting that the stock is trading at a premium compared to its historical valuation.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
2026-06-25 15:54 1mo ago
2026-06-25 10:46 1mo ago
FLEX vs. PLXS: Which Electronics Manufacturing Stock is the Better Buy?
PLXS Plexus
FMP Stock News
Original source text
Key Takeaways Flex plans a CPI spin-off as it sharpens focus on healthcare, robotics and networking markets.FLEX expects fiscal 2027 revenue growth of 18% at midpoint and adjusted EPS growth of 32%.PLXS posted record program wins, but lower free cash flow guidance and customer concentration pose risks. Flex Ltd. (FLEX - Free Report) and Plexus Corp. (PLXS - Free Report) are benefiting from favorable trends in the electronics manufacturing industry, supported by growing demand across advanced technologies and infrastructure markets. Flex is expanding its presence in AI-driven data center infrastructure through its power, cooling and compute integration capabilities, while also strengthening its portfolio through strategic investments and acquisitions. Plexus, meanwhile, is capitalizing on strong manufacturing program wins and growing opportunities across industrial, healthcare, aerospace and defense markets, including data center power and automation applications.

Both companies are leveraging their engineering, manufacturing and supply chain expertise to pursue growth opportunities in attractive end markets. As demand for advanced electronics, automation, AI infrastructure and mission-critical applications continues to rise, both Flex and Plexus remain focused on expanding their capabilities, improving operational performance and supporting long-term growth initiatives.

Let’s analyze their fundamentals, growth opportunities, market challenges and valuation to assess which one presents a stronger investment opportunity.

The Case for FLEXFlex is benefiting from its ongoing transformation toward higher-value, technology-intensive markets, a strategy that has strengthened its positioning for long-term growth. Over the past seven years, the company has streamlined its portfolio by exiting consumer-focused businesses, divesting non-core assets and investing in advanced technologies while maintaining disciplined execution. The planned spin-off of its Cloud and Power Infrastructure (CPI) business represents the next phase of this strategy, allowing both organizations to sharpen their focus, improve capital allocation and pursue growth opportunities more effectively. Following the separation, Flex will concentrate on advanced manufacturing markets such as healthcare, robotics, warehouse automation and networking.

The company is also gaining from the rapid growth of AI-driven data center infrastructure. Its CPI business has developed a differentiated end-to-end platform that combines power infrastructure, thermal management and compute integration, enabling customers to work with a single provider instead of multiple vendors. Management believes that the transition toward integrated power and cooling architectures, along with emerging technologies such as solid-state transformers and 800-volt DC distribution, creates a substantial long-term opportunity. These capabilities position Flex to benefit from the increasing complexity and power demands of next-generation AI data centers.

Flex continues to enhance its competitive position through strategic investments and acquisitions. The acquisition of Electrical Power Products (EP2) broadened its utility-grade power solutions portfolio and strengtheed its ability to support grid modernization and electrification initiatives. The company has also secured significant new business from hyperscalers and data center customers, including Google, spanning power infrastructure, thermal systems and complex hardware manufacturing. These multiyear engagements provide diversified growth opportunities and support planned capacity expansion through fiscal 2027 and beyond.

The company’s strong financial performance further supports its growth outlook. In fiscal 2026, revenue increased 8%, adjusted operating income grew 21% and adjusted earnings per share rose 25%. Continued strength across cloud, power and industrial businesses, combined with operational improvements, enabled Flex to achieve record profitability and generate approximately $1.1 billion in free cash flow. Management expects fiscal 2027 revenue to reach $32.3-$33.8 billion, representing 18% growth at the midpoint, while adjusted EPS is projected to increase 32%. The CPI business is expected to deliver revenue growth of 65-75% in fiscal 2027 and more than 80% in fiscal 2028, supported by expanding AI infrastructure demand, multiyear contracts and continued margin expansion.

Despite these strengths, Flex faces several near-term challenges. The Integrated Technology Solutions segment continues to be adversely impacted by weakness in lifestyle and consumer-related markets, leading the company to further reduce its exposure to lower-value businesses. At the same time, elevated capital expenditures and infrastructure investments within the CPI segment are temporarily pressuring margins and limiting free cash flow conversion. Although management expects these investments to generate higher returns over time, execution risks related to the planned spin-off, capacity expansion initiatives and large-scale AI infrastructure projects remain important considerations.

The Case for PLXSPlexus continues to benefit from strong program ramp activity and a growing pipeline of manufacturing opportunities. Fiscal second-quarter 2026 revenues increased 18.7% year over year to $1.164 billion, supported by 30 manufacturing program wins expected to generate approximately $355 million in annualized revenue once fully ramped into production. These wins were diversified across Industrial, Healthcare/Life Sciences and Aerospace/Defense markets, with notable exposure to growth areas such as data center power, automation, robotics, semiconductor capital equipment and defense platforms. Management noted that record program wins and improving market demand position the company to achieve mid-teens or higher revenue growth in fiscal 2026, while its qualified opportunity pipeline has expanded to $4 billion.

The company also maintains a solid financial foundation supported by healthy cash generation and disciplined capital allocation. During the fiscal second quarter, Plexus generated $28.5 million in operating cash flow and $16 million in free cash flow, exceeding expectations despite continued investments in the business. Strong cash generation has enabled the company to repurchase shares and reduce debt, including $20.6 million of share buyback during the quarter. Over the long term, management targets annual revenue growth of 9-12% while achieving a 15% ROIC, supporting sustained shareholder value creation.

However, the company’s revenue in the Healthcare segment is expected to remain flat sequentially in the current quarter, while certain Industrial subsectors continue to experience weak demand conditions. Management also guided for slightly lower gross margins at the midpoint for the fiscal third quarter due to program ramp timing, ongoing investments and higher incentive compensation expenses. In addition, uncertainty surrounding evolving trade policies continues to create a challenging macroeconomic backdrop.

Near-term cash flow is expected to come under pressure as the company increases investments in working capital to support revenue growth. Management expects the current quarter to result in a use of cash and has lowered its fiscal 2026 free cash flow outlook to $50-$75 million from its previous expectation of $100 million. Higher working capital requirements, along with planned capital expenditures of $100-$120 million, are expected to weigh on cash generation. Any delays in revenue ramps, customer order timing or inventory turnover could further affect free cash flow performance.

Another key risk is Plexus’ dependence on a relatively small group of large customers. The top 10 customers accounted for 54% of revenue in the second quarter of fiscal 2026, up from 52% in the prior quarter and 51% in the year-ago period. This concentration exposes the company to customer-specific risks, as the loss of a major customer or project could negatively impact financial results. Additionally, Plexus provides most of its manufacturing services on a turnkey basis, which requires higher investment levels and increases operational and execution risks within a highly competitive industry.

FLEX vs. PLXS Share Price PerformanceOver the past six months, FLEX shares have gained 138%, while Plexus has soared 85.8%.

Image Source: Zacks Investment Research

Valuation for FLEX & PLXSIn terms of Price/Book, FLEX shares are trading at 10.77X, higher than PLXS’ 5.15X.

Image Source: Zacks Investment Research

How Do Estimates Compare for FLEX & PLXS?Analysts have significantly revised their earnings estimates upward for FLEX’s bottom line for the current year.

Image Source: Zacks Investment Research

For PLXS, there have been upward revisions for the current year.

Image Source: Zacks Investment Research

FLEX or PLXS: Which Stock to Bet On?While FLEX sports a Zacks Rank #1 (Strong Buy) at present, PLXS has a Zacks Rank #4 (Sell). Consequently, in terms of Zacks Rank and valuation, FLEX seems to be a better pick at the moment.

You can see the complete list of today’s Zacks #1 Rank stocks here.
2026-06-12 15:11 1mo ago
2026-03-22 05:06 4mo ago
Plexus (NASDAQ:PLXS) CEO Sells $291,360.00 in Stock
PLXS Plexus
FMP Stock News
Original source text
Plexus Corp. (NASDAQ: PLXS - Get Free Report) CEO Todd Kelsey sold 1,500 shares of the firm's stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $194.24, for a total transaction of $291,360.00. Following the completion of the sale, the chief executive officer owned 81,791 shares of the
2026-06-12 15:11 1mo ago
2026-03-27 10:37 4mo ago
PLXS Stock Up 32% in 3 Months: Is There Further Upside Left?
PLXS Plexus
FMP Stock News
Original source text
Plexus Corporation PLXS has emerged as a compelling performer in the electronics manufacturing services (EMS) space, with the stock price appreciating 32.3% over the past three months, outperforming the Electronic Manufacturing Industry's growth of 8.7%. The S&P 500 composite and the broader Computer Technology Sector have declined 4.8% and 6.7%, respectively.
2026-06-12 15:11 1mo ago
2026-04-01 04:43 4mo ago
Plexus Corp. (NASDAQ:PLXS) Given Consensus Rating of “Moderate Buy” by Analysts
PLXS Plexus
FMP Stock News
Original source text
Posted by Defense World Staff on Apr 1st, 2026

Shares of Plexus Corp. (NASDAQ:PLXS – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six research firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $194.20.

Several analysts have recently weighed in on the stock. Zacks Research upgraded shares of Plexus from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 6th. Wall Street Zen cut Plexus from a “buy” rating to a “hold” rating in a research note on Sunday, March 8th. Williams Trading set a $195.00 price target on Plexus in a research report on Wednesday, January 28th. Needham & Company LLC lifted their price target on Plexus from $165.00 to $206.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Finally, Benchmark reiterated a “buy” rating and issued a $220.00 price objective on shares of Plexus in a report on Monday, March 16th.

Check Out Our Latest Analysis on PLXS

Plexus Stock Performance Shares of PLXS opened at $202.54 on Wednesday. Plexus has a 12-month low of $103.43 and a 12-month high of $220.17. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. The company has a market cap of $5.43 billion, a PE ratio of 31.50 and a beta of 0.81. The stock has a 50-day moving average price of $196.39 and a 200-day moving average price of $165.55.

Plexus (NASDAQ:PLXS – Get Free Report) last posted its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.07 billion. During the same period in the prior year, the business earned $1.73 earnings per share. Plexus’s revenue for the quarter was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. As a group, equities analysts forecast that Plexus will post 5.9 earnings per share for the current fiscal year.

Insider Buying and Selling In other Plexus news, CFO Patrick John Jermain sold 2,321 shares of the business’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $201.12, for a total value of $466,799.52. Following the completion of the sale, the chief financial officer directly owned 14,561 shares of the company’s stock, valued at $2,928,508.32. The trade was a 13.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Oliver K. Mihm sold 9,541 shares of the company’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $201.40, for a total transaction of $1,921,557.40. Following the sale, the chief operating officer owned 12,809 shares of the company’s stock, valued at approximately $2,579,732.60. The trade was a 42.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 49,495 shares of company stock worth $10,009,836 over the last ninety days. Corporate insiders own 1.78% of the company’s stock.

Institutional Investors Weigh In On Plexus Hedge funds and other institutional investors have recently modified their holdings of the stock. Inspire Investing LLC boosted its holdings in Plexus by 1.6% in the 4th quarter. Inspire Investing LLC now owns 3,178 shares of the technology company’s stock worth $467,000 after buying an additional 50 shares during the period. Allworth Financial LP raised its holdings in Plexus by 20.8% during the fourth quarter. Allworth Financial LP now owns 302 shares of the technology company’s stock valued at $44,000 after acquiring an additional 52 shares during the period. Maryland State Retirement & Pension System lifted its position in shares of Plexus by 1.5% in the fourth quarter. Maryland State Retirement & Pension System now owns 3,940 shares of the technology company’s stock valued at $579,000 after acquiring an additional 60 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its stake in shares of Plexus by 1.2% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,175 shares of the technology company’s stock worth $908,000 after acquiring an additional 71 shares during the period. Finally, Uncommon Cents Investing LLC boosted its stake in shares of Plexus by 0.8% in the fourth quarter. Uncommon Cents Investing LLC now owns 9,925 shares of the technology company’s stock worth $1,459,000 after acquiring an additional 75 shares during the period. Institutional investors own 94.45% of the company’s stock.

Plexus Company Profile (Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Featured Articles Five stocks we like better than Plexus

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEEverus Construction Group, Inc. (NYSE:ECG) Given Consensus Rating of “Moderate Buy” by Brokerages

NEXT HEADLINE »The Goldman Sachs Group Issues Positive Forecast for Bicara Therapeutics (NASDAQ:BCAX) Stock Price
2026-06-12 15:11 1mo ago
2026-04-01 13:01 4mo ago
Plexus (PLXS) Is Up 2.14% in One Week: What You Should Know
PLXS Plexus
FMP Stock News
Original source text
Does Plexus (PLXS) have what it takes to be a top stock pick for momentum investors? Let's find out.
2026-06-12 15:10 1mo ago
2026-04-08 04:47 3mo ago
SG Americas Securities LLC Sells 8,112 Shares of Plexus Corp. $PLXS
PLXS Plexus
FMP Stock News
Original source text
Posted by Defense World Staff on Apr 8th, 2026

SG Americas Securities LLC lessened its position in Plexus Corp. (NASDAQ:PLXS – Free Report) by 48.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,521 shares of the technology company’s stock after selling 8,112 shares during the period. SG Americas Securities LLC’s holdings in Plexus were worth $1,253,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. American Century Companies Inc. increased its stake in Plexus by 44.2% in the third quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock valued at $159,722,000 after purchasing an additional 338,119 shares in the last quarter. Massachusetts Financial Services Co. MA increased its stake in Plexus by 23.3% in the third quarter. Massachusetts Financial Services Co. MA now owns 240,192 shares of the technology company’s stock valued at $34,753,000 after purchasing an additional 45,425 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Plexus by 28.3% in the third quarter. JPMorgan Chase & Co. now owns 240,460 shares of the technology company’s stock valued at $34,792,000 after purchasing an additional 52,967 shares in the last quarter. Nicola Wealth Management LTD. bought a new stake in Plexus in the third quarter valued at approximately $6,655,000. Finally, Vanguard Group Inc. increased its stake in Plexus by 0.6% in the third quarter. Vanguard Group Inc. now owns 3,683,845 shares of the technology company’s stock valued at $533,016,000 after purchasing an additional 22,374 shares in the last quarter. Institutional investors own 94.45% of the company’s stock.

Plexus Price Performance Shares of NASDAQ:PLXS opened at $207.87 on Wednesday. The firm has a 50 day moving average of $199.37 and a 200-day moving average of $167.93. The stock has a market capitalization of $5.57 billion, a PE ratio of 32.33 and a beta of 0.75. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. Plexus Corp. has a 12 month low of $108.21 and a 12 month high of $220.17.

Plexus (NASDAQ:PLXS – Get Free Report) last announced its quarterly earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.07 billion. During the same period in the previous year, the firm posted $1.73 EPS. The firm’s revenue was up 9.6% on a year-over-year basis. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, equities research analysts predict that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Wall Street Analyst Weigh In Several brokerages have commented on PLXS. Wall Street Zen downgraded shares of Plexus from a “buy” rating to a “hold” rating in a research note on Sunday, March 8th. Weiss Ratings raised shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, March 6th. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 6th. Needham & Company LLC increased their price objective on shares of Plexus from $165.00 to $206.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. Finally, Stifel Nicolaus increased their price objective on shares of Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a research report on Friday, January 30th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $194.20.

Check Out Our Latest Research Report on PLXS

Insider Buying and Selling at Plexus In related news, COO Oliver K. Mihm sold 9,541 shares of the stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $201.40, for a total transaction of $1,921,557.40. Following the transaction, the chief operating officer directly owned 12,809 shares of the company’s stock, valued at $2,579,732.60. This represents a 42.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Dean A. Foate sold 5,000 shares of the company’s stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $204.89, for a total transaction of $1,024,450.00. Following the transaction, the chairman owned 15,000 shares in the company, valued at approximately $3,073,350. The trade was a 25.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 49,495 shares of company stock valued at $10,009,836 over the last 90 days. Insiders own 1.78% of the company’s stock.

Plexus Profile (Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Read More Five stocks we like better than Plexus Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINESG Americas Securities LLC Increases Position in ePlus inc. $PLUS

NEXT HEADLINE »SG Americas Securities LLC Increases Stock Holdings in Autohome Inc. $ATHM
2026-06-12 15:10 1mo ago
2026-04-27 18:16 3mo ago
Sanmina (SANM) Tops Q2 Earnings and Revenue Estimates
PLXS Plexus
FMP Stock News
Original source text
Sanmina (SANM) came out with quarterly earnings of $3.16 per share, beating the Zacks Consensus Estimate of $2.42 per share. This compares to earnings of $1.41 per share a year ago.
2026-06-12 15:10 1mo ago
2026-04-29 16:15 3mo ago
Plexus Announces Fiscal Second Quarter Financial Results
PLXS Plexus
FMP Stock News
Original source text
NEENAH, WI, April 29, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal second quarter ended April 4, 2026, and guidance for our fiscal third quarter ending July 4, 2026.

Reports record fiscal second quarter 2026 revenue of $1.164 billion, GAAP operating margin of 5.3% and GAAP diluted EPS of $1.82.Reports fiscal second quarter 2026 non-GAAP operating margin of 6.0% and non-GAAP diluted EPS of $2.05, excluding $0.23 of stock-based compensation expense.Initiates fiscal third quarter 2026 revenue guidance of $1.200 billion to $1.250 billion with GAAP diluted EPS of $1.25 to $1.41, including $0.77 of stock-based compensation expense. Fiscal third quarter non-GAAP EPS guidance of $2.02 to $2.18 excludes stock-based compensation expense.
  Three Months Ended  Apr 4, 2026 Apr 4, 2026 Jul 4, 2026  Q2F26 Results Q2F26 Guidance Q3F26 GuidanceSummary GAAP Items     Revenue (in billions)$1.164  $1.110 to $1.150 $1.200 to $1.250Operating margin 5.3%  4.9% to 5.3% 4.1% to 4.5%Diluted EPS$1.82  $1.53 to $1.68 $1.25 to $1.41       Summary Non-GAAP Items (1)     Adjusted operating margin (2) 6.0%  5.6% to 6.0% 5.9% to 6.3%Adjusted EPS (3)$2.05  $1.80 to $1.95 $2.02 to $2.18Return on invested capital (ROIC) 13.8%     Economic return 4.8%            (1) Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.
(2) Excludes stock-based compensation expense of approximately 70 bps for Q2F26 results and Q2F26 guidance and 180 bps for Q3F26 guidance.
(3)Excludes stock-based compensation expense, net of tax, of $0.23 for Q2F26 results, $0.27 for Q2F26 guidance and $0.77 for Q3F26 guidance.
Fiscal Second Quarter 2026 Information

Won 30 manufacturing programs during the quarter representing a record $355 million in annualized revenue when fully ramped into production.Generated free cash flow of $16.0 million. Purchased $20.6 million of our shares at an average price of $189.22 per share under our 2026 Share Repurchase Program, leaving $42.0 million available under our existing $100.0 million authorization.
Todd Kelsey, President and Chief Executive Officer, commented, “Our momentum is accelerating broadly. For the fiscal second quarter, we increased revenue significantly year-over-year, delivered record manufacturing wins, expanded our efficiency efforts and generated robust profitability. We produced record revenue of $1.164 billion, which exceeded our guidance range and increased 19% year-over-year with significant contributions from all market sectors. In addition, non-GAAP operating margin of 6.0% met the high end of guidance, while non-GAAP EPS of $2.05 exceeded guidance.”

Mr. Kelsey added, “Our go-to-market team achieved record quarterly manufacturing wins of $355 million in annualized revenue. This included broad-based programs in aerospace and defense, expanded relationships and share gains in surgical and imaging platforms, a new engagement in data center power solutions and continued share gains in semiconductor capital equipment. While achieving this tremendous wins result, we also expanded our funnel of qualified manufacturing opportunities.”

Patrick Jermain, Executive Vice President and Chief Financial Officer, commented, “Our fiscal second quarter cash cycle of 64 days represented a better-than-expected sequential improvement of 5 days, the benefit of continued progress on working capital initiatives and stronger-than-guided revenue. Our favorable cash cycle combined with our strong operating performance produced a fiscal second quarter return on invested capital of 13.8%, which exceeded our cost of capital by 480 basis points. We also delivered $16 million in free cash flow for the fiscal second quarter, a result that surpassed our projections. We are strategically increasing working capital investments in support of accelerating revenue growth, with an expectation to maintain cash cycle days consistent with our recent performance. As a result, we now expect to generate fiscal 2026 free cash flow in the range of $50 to $75 million.”

Mr. Kelsey continued, “We anticipate continued strong performance for our fiscal third quarter from program ramps, improved end-market demand and our sustained focus on operational efficiency. We are guiding revenue of $1.200 to $1.250 billion, representing 5% sequential and 20% year-over-year growth at the midpoint, non-GAAP operating margin of 5.9% to 6.3% and non-GAAP EPS of $2.02 to $2.18.”

Mr. Kelsey concluded, “Plexus’ consistent focus on redefining excellence through our unmatched quality and delivery is shaping our decision-making and sustaining our tremendous momentum. Leveraging this momentum, and our excellent financial performance year to date, we now expect Plexus to deliver mid-teens or greater fiscal 2026 revenue growth, with robust operating performance.”

Quarterly ComparisonThree Months Ended(in thousands, except EPS)Apr 4, 2026 Jan 3, 2026 Mar 29, 2025Revenue$1,163,757  $1,069,852  $980,170 Gross profit 119,176   106,138   97,751 Operating income 61,837   54,464   48,791 Net income 49,809   41,182   39,073 Diluted EPS$1.82  $1.51  $1.41       Gross margin 10.2%   9.9%   10.0%Operating margin 5.3%   5.1%   5.0%      ROIC (1) 13.8%   13.2%   13.7%Economic return (1) 4.8%   4.2%   4.8%      (1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return. Business Segment and Market Sector Revenue

Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised 54% of revenue during the second quarter of fiscal 2026. This is up 2 percentage points from the first quarter of fiscal 2026 and up 3 percentage points from the second quarter of fiscal 2025.

Business Segments ($ in millions)Three Months Ended  Apr 4, 2026 Jan 3, 2026 Mar 29, 2025Americas$397  $345  $295 Asia-Pacific 652   612   587 Europe, Middle East and Africa 116   118   103 Elimination of inter-segment sales (1)   (5)   (5) Total Revenue$1,164  $1,070  $980         Market Sectors ($ in millions)Three Months Ended Apr 4, 2026 Jan 3, 2026 Mar 29, 2025Aerospace/Defense$21218%  $17817%  $17218% Healthcare/Life Sciences 47341%   46643%   41142% Industrial 47941%   42640%   39740% Total Revenue$1,164  $1,070  $980  Non-GAAP Supplemental Information

Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow, because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.

ROIC and Economic Return

ROIC for the second quarter of fiscal 2026 was 13.8%. Plexus defines ROIC as tax-effected annualized adjusted operating income divided by average invested capital over a three-quarter period for the second fiscal quarter. Invested capital is defined as equity plus debt and operating lease obligations, less cash and cash equivalents. Plexus' weighted average cost of capital for fiscal 2026 is 9.0%. ROIC for the second quarter of fiscal 2026 less Plexus’ weighted average cost of capital resulted in an economic return of 4.8%.

Free Cash Flow

Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended April 4, 2026, cash flows provided by operations was $28.5 million and capital expenditures were $12.5 million, which resulted in free cash flow of $16.0 million.

Cash Cycle DaysThree Months Ended  Apr 4, 2026 Jan 3, 2026 Mar 29, 2025Days in Accounts Receivable55  58  57 Days in Contract Assets12  13  12 Days in Inventory120  124  132 Days in Accounts Payable(74)  (71)  (70) Days in Advanced Payments(49)  (55)  (63) Annualized Cash Cycle (1)64  69  68        (1) Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.
Conference Call and Webcast Information

What:   Plexus Fiscal 2026 Q2 Earnings Conference Call and WebcastWhen:   Thursday, April 30, 2026 at 8:30 a.m. Eastern TimeWhere:   Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below:Webcast link:
https://events.q4inc.com/attendee/177402160

Replay:   The webcast will be archived on the Plexus website and will be available as on-demand for 12 months Investor and Media Contact
Shawn Harrison
+1.920.969.6325
[email protected]

About Plexus
At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For more information about Plexus, visit our website at www.plexus.com.

Safe Harbor and Fair Disclosure Statement
The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of shortages, delays and price fluctuations in obtaining components as a result of economic cycles, capacity constraints, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate engagement terms, and the lack of a track record of order volume and timing; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customers and deliver product on a timely basis; the risks of concentration of work for certain customers; the effects of start-up costs of new programs and facilities or the costs associated with winding down programs or the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of the economy regionally or globally; the effect of changes in the pricing and margins of our services; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and regulatory matters in the United States and in the other countries in which we do business; the potential effect of other events outside our control, such as the conflict between Russia and Ukraine, conflict in the Middle East (including in Iran), escalating tensions between China and Taiwan or China and the United States, tensions in or amongst countries in which we operate or transact business, changes in energy prices, terrorism, global health epidemics and weather events; the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2025 Form 10-K.

PLEXUS CORP. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data)(unaudited)       Three Months Ended Six Months Ended Apr 4, Mar 29, Apr 4, Mar 29, 2026
 2025
 2026
 2025
Net sales$1,163,757  $980,170  $2,233,609  $1,956,292 Cost of sales 1,044,581   882,419   2,008,295   1,757,849 Gross profit 119,176   97,751   225,314   198,443 Operating expenses:       Selling and administrative expenses 57,339   48,960   109,013   98,109 Restructuring and other charges, net —   —   —   4,683 Operating income 61,837   48,791   116,301   95,651 Other income (expense):       Interest expense (3,422)   (3,137)   (6,310)   (6,691) Interest income 812   871   1,796   2,105 Miscellaneous, net (1,350)   (1,502)   (2,878)   (2,548) Income before income taxes 57,877   45,023   108,909   88,517 Income tax expense 8,068   5,950   17,918   12,177 Net income$49,809  $39,073  $90,991  $76,340 Earnings per share:       Basic$1.86  $1.44  $3.40  $2.82 Diluted$1.82  $1.41  $3.32  $2.75 Weighted average shares outstanding:       Basic 26,757   27,109   26,762   27,098 Diluted 27,310   27,662   27,369   27,726  PLEXUS CORP. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(in thousands)(unaudited) Apr 4, Sep 27,  2026   2025 ASSETS   Current assets:   Cash and cash equivalents$303,133  $306,464 Restricted cash 48   294 Accounts receivable 702,339   656,573 Contract assets 160,382   150,654 Inventories 1,373,732   1,229,839 Prepaid expenses and other 97,569   54,969 Total current assets 2,637,203   2,398,793 Property, plant and equipment, net 535,171   546,052 Operating lease right-of-use assets 68,632   72,863 Deferred income taxes 91,663   91,349 Other assets 28,300   28,053 Total non-current assets 723,766   738,317 Total assets$3,360,969  $3,137,110     LIABILITIES AND SHAREHOLDERS’ EQUITY   Current liabilities:   Current portion of long-term debt and finance lease obligations$143,112  $45,793 Accounts payable 851,909   726,597 Advanced payments from customers 565,346   575,850 Accrued salaries and wages 90,924   109,076 Other accrued liabilities 60,989   61,367 Total current liabilities 1,712,280   1,518,683 Long-term debt and finance lease obligations, net of current portion 91,034   91,987 Long-term operating lease liabilities 25,769   29,422 Deferred income taxes 5,155   6,000 Other liabilities 36,931   36,430 Total non-current liabilities 158,889   163,839 Total liabilities 1,871,169   1,682,522 Shareholders’ equity:   Common stock 549   547 Additional paid-in-capital 689,909   695,653 Common stock held in treasury (1,298,881)   (1,255,451) Retained earnings 2,087,019   1,996,028 Accumulated other comprehensive income 11,204   17,811 Total shareholders’ equity 1,489,800   1,454,588 Total liabilities and shareholders’ equity$3,360,969  $3,137,110       PLEXUS CORP. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(in thousands)(unaudited)     Six Months Ended Apr 4, Mar 29, 2026
 2025
Cash flows from operating activities   Net income$90,991  $76,340 Adjustments to reconcile net income to net cash flows from operating activities:   Depreciation and amortization 38,493   38,925 Share-based compensation expense and related charges 15,685   14,771 Other, net (88)   (6,125) Changes in operating assets and liabilities, excluding impacts of currency:   Accounts receivable (47,335)   9,100 Contract assets (9,770)   (15,624) Inventories (145,413)   25,310 Other current and non-current assets (45,965)   (240) Accrued income taxes payable (7,006)   (12,390) Accounts payable 146,673   70,624 Advanced payments from customers (9,945)   (95,297) Other current and non-current liabilities (13,240)   (15,064) Cash flows provided by operating activities 13,080   90,330 Cash flows from investing activities   Payments for property, plant and equipment (47,650)   (46,726) Other, net (29)   (28) Cash flows used in investing activities (47,679)   (46,754) Cash flows from financing activities   Borrowings under debt agreements 384,500   127,000 Payments on debt and finance lease obligations (289,863)   (165,202) Repurchases of common stock (43,430)   (25,366) Payments related to tax withholding for share-based compensation (21,426)   (14,527) Cash flows provided by (used in) financing activities 29,781   (78,095) Effect of exchange rate changes on cash and cash equivalents 1,241   (2,381) Net decrease in cash and cash equivalents and restricted cash (3,577)   (36,900) Cash and cash equivalents and restricted cash:   Beginning of period 306,758   347,462 End of period$303,181  $310,562       PLEXUS CORP. AND SUBSIDIARIESNON-GAAP SUPPLEMENTAL INFORMATION Table 1(in thousands, except per share data)(unaudited)             Three Months Ended Six Months Ended  Apr 4, Jan 3, Mar 29, Apr 4, Mar 29,  2026
 2026
 2025
 2026
 2025
Operating income, as reported$61,837  $54,464  $48,791  $116,301  $95,651 Operating margin, as reported 5.3%   5.1%   5.0%   5.2%   4.9%            Non-GAAP adjustments:         Restructuring costs (1) —   —   —   —   4,683 Stock-based compensation 7,922   7,765   7,132   15,687   14,122 Non-GAAP operating income$69,759  $62,229  $55,923  $131,988  $114,456 Non-GAAP operating margin 6.0%   5.8%   5.7%   5.9%   5.9%            Net income, as reported$49,809  $41,182  $39,073  $90,991  $76,340            Non-GAAP adjustments:         Restructuring costs, net of tax (1) —   —   —   —   4,191 Stock-based compensation, net of tax 6,055   7,377   6,775   13,432   13,415 Adjusted net income$55,864  $48,559  $45,848  $104,423  $93,946            Diluted earnings per share, as reported$1.82  $1.51  $1.41  $3.32  $2.75            Non-GAAP per share adjustments:         Restructuring costs, net of tax (1) —   —   —   —   0.15 Stock-based compensation, net of tax 0.23   0.27   0.25   0.50   0.49 Adjusted diluted earnings per share$2.05  $1.78  $1.66  $3.82  $3.39            (1) During the six months ended March 29, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company’s workforce in the EMEA and AMER regions.
                                             PLEXUS CORP. AND SUBSIDIARIESNON-GAAP SUPPLEMENTAL INFORMATION Table 2(in thousands)(unaudited)      ROIC and Economic Return CalculationsSix Months Ended Three Months Ended Six Months Ended Apr 4, Jan 3, Mar 29, 2026
 2026
 2025
Operating income, as reported $116,301   $54,464   $95,651 Restructuring and other charges, net+ —  + —  + 4,683 Adjusted operating income $116,301   $54,464   $100,334  x 2  x 4  x 2          Adjusted annualized operating income $232,602   $217,856   $200,668 Adjusted effective tax ratex 17%  x 17%  x 13% Tax impact  39,542    37,036    26,087 Adjusted operating income (tax-effected) $193,060   $180,820   $174,581          Average invested capital÷$1,401,134  ÷$1,374,532  ÷$1,276,742 ROIC  13.8%    13.2%    13.7% Weighted average cost of capital- 9.0%  - 9.0%  - 8.9% Economic return  4.8%    4.2%    4.8%                 Average Invested Capital CalculationsApr 4, Jan 3, Sep 27, Jun 28, Mar 29, Dec 28, Sep 28,  2026
 2026
 2025
 2025
 2025
 2024
 2024
 Equity$1,489,800  $1,481,063  $1,454,588  $1,419,085  $1,351,675  $1,319,069  $1,324,825  Plus:              Debt and finance lease obligations - current 143,112   66,837   45,793   50,678   121,014   121,977   157,325  Operating lease obligations - current (1) 7,758   7,943   8,253   8,470   9,968   14,875   14,697  Debt and finance lease obligations - long-term 91,034   91,139   91,987   92,215   88,761   88,728   89,993  Operating lease obligations - long-term 25,769   27,327   29,422   31,192   32,720   35,124   32,275  Less: Cash and cash equivalents (303,133)   (248,825)   (306,464)   (237,567)   (310,531)   (317,161)   (345,109)   $1,454,340  $1,425,484  $1,323,579  $1,364,073  $1,293,607  $1,262,612  $1,274,006                  (1)Included in other accrued liabilities on the Condensed Consolidated Balance Sheets.
2026-06-12 15:10 1mo ago
2026-04-29 16:15 3mo ago
Plexus Announces Planned Chief Financial Officer Transition
PLXS Plexus
FMP Stock News
Original source text
NEENAH, WI, April 29, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) announced today that Patrick Jermain, Executive Vice President and Chief Financial Officer (CFO), has elected to retire after a distinguished 15-plus year career at Plexus, including 12 years as CFO.

As part of a disciplined succession planning process, Plexus’ Board of Directors has appointed David Abuhl to succeed Mr. Jermain as Senior Vice President and Chief Financial Officer, effective May 11, 2026. Mr. Abuhl currently serves as Plexus’ Senior Vice President-Finance and is a member of the Company’s Leadership Team. To ensure a seamless transition, Mr. Jermain will remain employed by the Company and serve in an advisory role until July 31, 2026.

Todd Kelsey, Plexus’ President and Chief Executive Officer, commented, “Pat has been an exceptional partner, and I am thankful for his 15 years of dedication to Plexus. His leadership, integrity and commitment to Plexus’ success have been instrumental in our growth journey. Pat’s legacy includes fostering a high-performance and high-integrity finance culture, cultivating a tenured finance leadership team with advanced skillsets and propelling Plexus to deliver higher levels of efficiency with tremendous financial results.”

Mr. Kelsey continued, “David has made an immediate impact since joining Plexus and our Leadership Team in September 2025. His extensive financial expertise, coupled with his passion for building high-performing teams, makes him the ideal leader to guide our finance organization. I am confident that his global perspective and strategic mindset will be significant assets as we continue with our growth journey.”

Prior to joining Plexus, Mr. Abuhl spent over 15 years at Kimberly-Clark Corporation in various leadership roles across finance, treasury and investor relations. He most recently served as CFO-Enterprise Supply Chain, with financial oversight of approximately $14 billion in cost of goods sold. His previous experience includes serving as EMEA Finance Director and CFO for Kimberly-Clark Professional, a business-to-business division spanning approximately 70 countries. Mr. Abuhl holds a Masters of Business Administration from the SMU Cox School of Business and a Bachelor of Arts degree in Business and Economics from Wheaton College.

Investor and Media Contact

Shawn Harrison
+1.920.969.6325
[email protected]

About Plexus Corp.

At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For more information about Plexus, visit our website at www.plexus.com.
2026-06-12 15:10 1mo ago
2026-04-29 19:41 3mo ago
Plexus (PLXS) Tops Q2 Earnings and Revenue Estimates
PLXS Plexus
FMP Stock News
Original source text
Plexus (PLXS - Free Report) came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $1.87 per share. This compares to earnings of $1.66 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +9.43%. A quarter ago, it was expected that this electronic manufacturing services company would post earnings of $1.77 per share when it actually produced earnings of $1.78, delivering a surprise of +0.56%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Plexus, which belongs to the Zacks Electronics - Manufacturing Services industry, posted revenues of $1.16 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 2.99%. This compares to year-ago revenues of $980.17 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Plexus shares have added about 67.6% since the beginning of the year versus the S&P 500's gain of 4.3%.

What's Next for Plexus?While Plexus has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Plexus was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.00 on $1.15 billion in revenues for the coming quarter and $7.74 on $4.52 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Electronics - Manufacturing Services is currently in the top 10% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

C3.ai, Inc. (AI - Free Report) , another stock in the broader Zacks Computer and Technology sector, has yet to report results for the quarter ended April 2026.

This company is expected to post quarterly loss of $0.38 per share in its upcoming report, which represents a year-over-year change of -137.5%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

C3.ai, Inc.'s revenues are expected to be $49.75 million, down 54.2% from the year-ago quarter.
2026-06-12 15:10 1mo ago
2026-04-29 21:01 3mo ago
Plexus (PLXS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
PLXS Plexus
FMP Stock News
Original source text
For the quarter ended March 2026, Plexus (PLXS - Free Report) reported revenue of $1.16 billion, up 18.7% over the same period last year. EPS came in at $2.05, compared to $1.66 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.13 billion, representing a surprise of +2.99%. The company delivered an EPS surprise of +9.43%, with the consensus EPS estimate being $1.87.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Plexus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenue- Market Sector- Healthcare/Life Sciences: $473 million compared to the $478.74 million average estimate based on two analysts. The reported number represents a change of +15.1% year over year.Revenue- Market Sector- Aerospace/Defense: $212 million compared to the $189.08 million average estimate based on two analysts. The reported number represents a change of +23.3% year over year.Revenue- Market Sector- Industrial: $479 million compared to the $462.27 million average estimate based on two analysts. The reported number represents a change of +20.7% year over year.View all Key Company Metrics for Plexus here>>>

Shares of Plexus have returned +21.6% over the past month versus the Zacks S&P 500 composite's +12.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
2026-06-12 15:10 1mo ago
2026-04-30 14:35 3mo ago
Plexus' Q2 Earnings Surpass Estimates, Revenues Increase Y/Y
PLXS Plexus
FMP Stock News
Original source text
PLXS beats Q2 EPS estimates and posts higher revenues, fueled by strong program wins and rising demand, while boosting its fiscal 2026 growth outlook.
2026-06-12 15:10 1mo ago
2026-04-30 15:51 3mo ago
Plexus Corp. (PLXS) Q2 2026 Earnings Call Transcript
PLXS Plexus
FMP Stock News
Original source text
Plexus Corp. (PLXS) Q2 2026 Earnings Call Transcript
2026-06-12 15:10 1mo ago
2026-05-01 10:50 3mo ago
Here's Why Plexus (PLXS) is a Strong Momentum Stock
PLXS Plexus
FMP Stock News
Original source text
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.

It also includes access to the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.

Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.93% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.

That's where the Style Scores come in.

To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.

A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Plexus (PLXS - Free Report) Founded in 1979, Neenah, WI-based Plexus Corp. is a leading provider of electronic contract manufacturing services to original equipment manufacturers (OEMs) in a wide range of industries, including Healthcare/Life Sciences, Industrial and Aerospace/Defense market sectors.

PLXS is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.

Momentum investors should take note of this Computer and Technology stock. PLXS has a Momentum Style Score of A, and shares are up 20.9% over the past four weeks.

One analyst revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.02 to $7.74 per share. PLXS boasts an average earnings surprise of +9.4%.

With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, PLXS should be on investors' short list.
2026-06-12 15:10 1mo ago
2026-05-01 17:29 3mo ago
Is Plexus Corp (PLXS) Overvalued After 5.6% Rally? GF Value Says Overvalued
PLXS Plexus
FMP Stock News
Original source text
On May 01, 2026, Plexus Corp PLXS shares experienced a notable rise of 5.6%, bringing the current price to $264.60. Over the past week, shares have increased by 4.1% and have shown remarkable growth of 27.7% over the last month. Year-to-date, PLXS has soared by 80.0%, and over the past year, the stock has gained an impressive 113.1%. The stock's performance has been characterized by a 52-week range, hitting a high of $272.08 and a low of $115.35.

GF Value™ verdict: Current price is $264.60, significantly above GF Value™ of $142.73, indicating an 85.4% overvaluation.GF Score™: 87/100 (Strong), suggesting robust fundamentals.Most notable signal: Insiders sold $13.4M worth of shares in the last 3 months, with no purchases reported. Is PLXS Overvalued or Undervalued? According to GF Value™, Plexus Corp is currently overvalued, with the stock trading at $264.60 compared to an estimated fair value of $142.73. This represents a significant 85.4% margin of overvaluation, which raises concerns about the sustainability of the current price level. The GF Valuation label classifies the stock as "Significantly Overvalued," indicating that the current market price does not reflect the intrinsic value based on historical performance and future growth projections. Investors may face risks if the stock price corrects toward its GF Value™, as the substantial gap suggests that market optimism might not be justified by the company's financial fundamentals.

GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates. The overvaluation signals potential corrections in the future, making it essential for investors to exercise caution and conduct thorough analyses before making investment decisions.

How Does PLXS's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 38.7x 21.4x Forward P/E 34.3x N/A The current P/E ratio of 38.7x is significantly above the 5-year median P/E of 21.4x, indicating that the stock is trading at a premium compared to its historical valuation. This analysis aligns with the GF Value™ verdict of overvaluation, as the elevated P/E suggests that investors are paying considerably more for each dollar of earnings than they have historically.

What Does PLXS's GF Score™ Tell Us? Metric Rating GF Score™ 87/100 Financial Strength 8/10 Profitability 8/10 Growth 9/10 Valuation 3/10 Momentum 6/10 The GF Score™ of 87/100 suggests that Plexus Corp has strong fundamentals, particularly in growth (9/10) and financial strength (8/10). However, the valuation score of 3/10 indicates that the stock is currently overvalued relative to its intrinsic value. While the company's growth prospects and financial stability appear robust, the low valuation score is a critical concern for potential investors, highlighting the risk of holding an overvalued stock.

What Are Insiders Doing with PLXS Stock? Recent insider activity for Plexus Corp has shown that insiders have sold $13.4 million worth of shares in the last three months, with no reported purchases. This trend of selling may indicate a lack of confidence among insiders regarding the stock's current valuation and future price trajectory. When insiders sell significant amounts of their holdings without accompanying purchases, it often raises concerns among investors about potential future performance.

What This Means for Investors Based on the current analysis, Plexus Corp PLXS is classified as overvalued according to the GF Value™, which suggests that the stock price is significantly higher than its intrinsic value. Investors should weigh the strong fundamentals against the risks associated with such an overvaluation before making any investment decisions.

For the complete analysis, visit the Plexus Corp PLXS stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is PLXS's GF Score™?

The GF Score™ for Plexus Corp is 87/100, indicating strong fundamentals and a higher likelihood of generating long-term returns.

Is PLXS overvalued or undervalued?

Plexus Corp is overvalued according to the GF Value™, which estimates the fair value at $142.73, significantly lower than the current price of $264.60.

What is PLXS's P/E ratio?

The current P/E ratio for Plexus Corp is 38.7x, which is substantially higher than its historical 5-year median of 21.4x, indicating that the stock is trading at a premium.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
2026-06-12 15:10 1mo ago
2026-05-29 12:31 2mo ago
Plexus (PLXS) Up 6.9% Since Last Earnings Report: Can It Continue?
PLXS Plexus
FMP Stock News
Original source text
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock?
2026-06-12 15:10 1mo ago
2026-06-01 08:30 2mo ago
Plexus Issues Fiscal 2025 Sustainability Report and Announces Transition to Absolute Emission Reduction Targets
PLXS Plexus
FMP Stock News
Original source text
NEENAH, WI, June 01, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced the release of its Fiscal 2025 Sustainability Report. The report, which is now available on the Sustainability page of plexus.com, marks a significant evolution from intensity-based metrics to measurable, absolute emissions reduction goals. The report details the company’s progress in environmental stewardship, social responsibility and corporate governance, while marking a significant strategic evolution in its climate commitments.

The fiscal 2025 report highlights Plexus’ formal transition from intensity-based emissions goals to absolute emissions reduction targets. This shift aligns the company’s emission reduction strategy with leading international standards and underscores its commitment to achieving a sustainable global footprint and delivering robust revenue growth.

“At Plexus, our vision is to help create the products that build a better world. Our Fiscal 2025 Sustainability Report reflects our commitment to transparency and living that vision every day,” commented Todd Kelsey, President and Chief Executive Officer. “By transitioning to absolute emission reduction targets, we are taking a bold step in our sustainability journey, ensuring that our environmental impact remains a focus as we continue to innovate for our customers and create long-term shareholder value.”

Key Highlights from the fiscal 2025 Sustainability Report:

Emissions Reduction | Introduces a formal commitment to reduce emissions by 2033.Circularity and Waste Management | Successfully scaled its circularity footprint by more than doubling its number of zero waste sites to eight global locations.Social Impact and Community Engagement | Advanced its commitment to social responsibility by contributing over $1.4 million to local causes championed by our team members.Holistic Team Member Well-Being | Prioritized mental health by providing specialized support that delivers care four times faster than a traditional Employee Assistance Program (EAP).Trust and Transparency | Streamlined reporting through a new Indices framework, enhancing disclosure alignment with the Global Reporting Initiative (GRI) and the Task Force on Climate-related Financial Disclosures (TCFD).
The Fiscal 2025 Sustainability Report is available for download on the Sustainability page of plexus.com.

Investor and Media Contact

Shawn Harrison
+1.920.969.6325
[email protected] 

About Plexus
At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 27 facilities. For more information about Plexus, visit our website at www.plexus.com. 

Safe Harbor and Fair Disclosure Statement
The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of shortages, delays and price fluctuations in obtaining components as a result of economic cycles, capacity constraints, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate engagement terms, and the lack of a track record of order volume and timing; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customers and deliver product on a timely basis; the risks of concentration of work for certain customers; the effects of start-up costs of new programs and facilities or the costs associated with winding down programs or the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of the economy regionally or globally; the effect of changes in the pricing and margins of our services; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and regulatory matters in the United States and in the other countries in which we do business; the potential effect of other events outside our control, such as the conflict between Russia and Ukraine, conflict in the Middle East (including in Iran), escalating tensions between China and Taiwan or China and the United States, tensions in or amongst countries in which we operate or transact business, changes in energy prices, terrorism, global health epidemics and weather events; the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2025 Form 10-K.
2026-06-12 15:10 1mo ago
2026-06-02 20:44 2mo ago
Plexus Corp (PLXS) Shares Surge 3.2% -- What GF Score of 81 Tells Investors
PLXS Plexus
FMP Stock News
Original source text
On June 02, 2026, Plexus Corp PLXS shares rose 3.2% today, currently priced at $280.25. The stock has experienced considerable price movement in the past year, with a 52-week range from $115.35 to $283.22.

GF Value™ verdict: The current price is $280.25, while GF Value™ estimates fair value at $146.60, indicating the stock is 91.2% overvalued.GF Score™: 81/100, which suggests a strong overall performance based on key financial aspects.Most notable signal: Insiders sold $5.3M in the last 3 months, with no buying activity reported. Is PLXS Overvalued or Undervalued? Plexus Corp PLXS is currently trading at $280.25, significantly above the GF Value™ estimate of $146.60. This represents an overvaluation of approximately 91.2%, which raises concerns regarding the stock's current price relative to its intrinsic value. The GF Valuation label classifies PLXS as significantly overvalued, suggesting that investors may face potential risks if they are buying at these elevated levels.

The margin of safety is crucial to consider in such scenarios. With the stock trading well above its GF Value™, investors may be exposed to considerable downside risk if the market corrects or if the company fails to meet heightened expectations. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.

How Does PLXS's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 41.0x 21.7x Forward P/E 29.9x N/A The current P/E ratio of Plexus Corp (41.0x) is significantly above its 5-year median P/E of 21.7x, indicating that the stock is trading at a premium compared to its historical valuation. The forward P/E of 29.9x further supports the notion that PLXS is overvalued, as it is also above historical norms. This P/E analysis aligns with the GF Value™ verdict, reinforcing the conclusion that Plexus Corp is currently overvalued.

What Does PLXS's GF Score™ Tell Us? The GF Score™ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Score™ values have been found to generate higher long-term returns (backtested 2006-2021).

Metric Rating GF Score™ 81 Financial Strength 8/10 Profitability 8/10 Growth 10/10 Valuation 1/10 Momentum 6/10 Plexus Corp exhibits a strong GF Score™ of 81/100, driven primarily by its exceptional growth rank of 10/10 and solid ratings in financial strength and profitability (both 8/10). However, the low valuation rank of 1/10 suggests that the stock is not priced attractively based on its current valuation metrics. This indicates a potential disconnect between the company's strong operational performance and its market price, which is notably inflated at present.

What Are Insiders Doing with PLXS Stock? In the past three months, insiders have sold $5.3 million worth of Plexus Corp stock, with no reported purchases. This trend of selling may signal a lack of confidence from those with intimate knowledge of the company, which could be interpreted as a cautionary sign for potential investors. While insider selling does not always indicate negative sentiment, the absence of buying activity amidst significant sales could suggest that insiders believe the stock is overvalued at current levels.

What This Means for Investors Based on the analysis of GF Value™, Plexus Corp PLXS is currently overvalued. With a significant disparity between the current share price and its intrinsic value as calculated by GF Value™, investors should exercise caution when considering an investment in this stock.

For the complete analysis, visit the Plexus Corp PLXS stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is PLXS's GF Score™?

PLXS has a GF Score™ of 81/100, indicating a strong overall performance based on key financial aspects and suggesting good long-term return potential.

Is PLXS overvalued or undervalued?

PLXS is currently overvalued, with a GF Value™ of $146.60 indicating a significant discrepancy from its current price of $280.25.

What is PLXS's P/E ratio?

PLXS's P/E (TTM) is 41.0x, which is 89% above its 5-year median P/E of 21.7x, indicating the stock is trading at a premium compared to its historical valuation.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].